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Summary 
Aim 
The aim of this longitudinal epidemiological study was to investigate possible 
associations between occupational exposure, respiratory symptoms and change in lung 
function among employees at a mineral fertiliser production plant. 
Material and methods 
Lung function indices (forced vital capacity (FVC), the forced expiratory volume in 1 
second (FEV1) and lung diffusing capacity (DLCO)) were measured in 2007 and 2010 
among employees at a fertiliser production plant. In 2007, 349 persons participated 
(86% of those eligible). Of the 283 participants remaining at work three years later, 6% 
did not participate in the second phase of lung function measurement. In addition to 
those participating in 2007, 34 additional employees participated in 2010, for a total of 
383 participants. The employees consented to spirometry test and diffusing capacity test 
and answered a respiratory symptoms questionnaire during each testing session. In 
2007, rhinometry was performed at the same time as the lung function testing. In 2010, 
the subjects at the plant answered a questionnaire on work history with an emphasis on 
the three-year follow-up period. The employees were classified in job groups by 
production department according to their principal affiliation during follow-up. Study 
participants tested only once were grouped in the department they served on the day of 
lung function testing. Employees in the administration or working in average less than 2 
hours/week in the production were assigned to the job-group “Other”. 
The exposure assessment was performed in 2007-08 in all the departments at the plant; 
ammonia, nitric acid, compound fertiliser, and calcium nitrate departments, as well as a 
shipping area. A total of 178 inhalable and 179 thoracic personal aerosol mass fraction 
samples were collected from randomly chosen workers (N=141), whereof 23% of the 
workers participated more than once. Masses of inhalable and thoracic aerosol fractions 
were measured gravimetrically. Water-soluble and water-insoluble aerosol fractions 
were analysed for the major constituents, Ca, K, Mg, and P. Concentrations of F−, NO2−, 
NO3−, PO43−and SO42− in the water-soluble aerosol fraction and leachates from 
impregnated gas filter-pads were analysed. NH3, CO, and NO2 were measured using 
direct-reading electrochemical sensors. 
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In addition, a sub study on exposure assessment using video exposure monitoring 
strategy was conducted during a week in May 2009 to identify short-term peak 
episodes. 
Results 
An adjusted, statistically significant decline in FEV1 of 18 mL/year during the follow-
up was found for the total group, but no significant decline in FVC. The workers in the 
nitric acid department had a statistically significant decline in FEV1, but the absolute 
decline was of the same magnitude as for those in the Ammonia and Compound 
fertiliser A departments. DLCO showed a statistically significant decline of 0.068 
mmol/min/kPa/year for the total group. The prevalence of selected self-reported 
respiratory symptoms; morning cough, cough with phlegm, cough with phlegm >3 
months/yr, and wheezing, varied between 6.5 to 26.2%, with only morning cough 
showing a statistical significant increase from 8.0% in 2007 to 13.7% in 2010. No 
association was found between respiratory symptoms and the decline in lung function 
indices, and borderline significant correlation was found between nasal patency and 
FEV1% predicted. The median inhalable and thoracic aerosol mass concentration 
exposure levels were 1.1 mg/m3 (min-max: <0.93 - 45) and 0.21 mg/m3 (min-max: 
<0.085 - 11), respectively. The highest median aerosol mass concentrations were found 
in the compound fertiliser departments with median inhalable mass air concentration of 
3.0 mg/m3 in Compound fertiliser C and median thoracic mass air concentration of 0.78 
mg/m3 in Compound fertiliser A. The median air concentrations of CO, NH3, and NO2 
in all departments were predominantly below the limit of detection (2 ppm, 3 ppm, 0.2 
ppm, respectively). However, some short-term peak episodes of NH3 and NO2 were 
detected, e.g. when performing tasks like cleaning and sampling for quality control. 
Conclusion 
An observed adjusted decline in lung function indices was found in this three-year 
follow-up of workers at a nitrate fertiliser plant. The prevalence of morning cough 
increased in the follow-up period, but no association between respiratory symptoms and 
decline in lung function indices was found. A borderline correlation was found between 
nasal patency and FEV1% predicted. The exposure levels for aerosols and gases were 
generally low with many measurements below the limit of detection. No plausible 
exposure related explanation for the overall lung function decline during follow-up was 
found. 
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Preface 
Employees in the fertiliser production industry might be exposed to aerosols from raw 
material and final products, acid aerosols, and various gases such as nitrogen dioxide 
and ammonia. The workers regularly receive health surveillance, including spirometry 
tests, at an occupational health service. 
This study was initiated after the occupational health service at Yara Porsgrunn, in a 
cross-sectional survey based on the health surveillance measurements, observed a 
higher prevalence of chronic obstructive pulmonary disease (COPD) (cut-off 
FEV1/FVC<0.7) among the workers in the fertiliser production areas compared to an 
internal control group; 9.5% versus 2%, respectively, at the beginning of this century 
(T. Grimstad, MD, personal communication). The occupational health service 
hypothesised that the findings were associated with air pollutants in the work 
environment. No detailed information on the exposure levels among workers in the 
production facilities was obtained in the company study. 
The company, as a consequence of aforementioned results, decided to further 
investigate possible associations between exposure and decline in lung function. Yara 
Porsgrunn requested the National Institute of Occupational Health to conduct a 
longitudinal study. The four-year study reported here was initiated in 2006 and included 
a prospective exposure assessment study during the three-year follow-up of lung 
function. 
 
Photo. Mineral fertiliser plant under study. © Yara ASA 
Background 
 12 
Background 
Lung function and occupational exposure 
Occupation was not considered an independent cause of chronic airflow limitation 
before the 1980ies (Becklake 1985). As recently as in 2010 Sigsgaard et al stated in an 
editorial; “Data on COPD related to occupation are scarce, since the only recognised 
risk factor for COPD, until very recent years, has been smoking” (Sigsgaard et al. 
2010). Obstructive pulmonary disease encompasses several respiratory diseases 
including asthma and COPD. The aim was to study the lung function decline during 
follow-up, as an adjusted decline may indicate an increased risk of developing COPD. 
Although tobacco smoking is considered the major risk factor for developing COPD, it 
is now well accepted that the population-attributable fraction (PAF) for the workplace 
contribution is approximately 15-20% (Eisner et al. 2010, Blanc et al. 2007, Korn et al. 
1987, Balmes 2005), although PAF as high as approximately 30% has been found 
among workers self-reporting exposure to gas, vapours, fumes, and aerosols (Blanc et 
al. 2009) and among never-smokers (Hnizdo et al. 2002), and as high as 50% among 
never-smoking Swedish construction workers (Bergdahl et al. 2004). In a Norwegian 
study, an estimated increased risk of respiratory symptoms or asthma among those 
exposed to dust and fumes was found to be 15% (Eagan et al. 2002). 
Because COPD is common in the population, even a small occupational contribution 
constitutes a challenge to public health. It has been estimated that approximately 250-
300 000 persons have varying degrees of COPD in Norway (Johannessen et al. 2005), 
consequently one can estimate 40 000 occupational related cases of COPD in Norway. 
Industry-specific studies have suggested occupational chronic obstructive pulmonary 
disease among coal-miners (Seixas et al. 1993), hard-rock miners (Hnizdo 1990) and 
industrial workers in Paris (Kauffmann et al. 1982). In Norway, studies among divers 
(Skogstad et al. 2008), tunnel workers (Ulvestad et al. 2001, Bakke, B et al. 2004), 
cement production workers (Fell et al. 2003, Nordby et al. 2011), aluminium potroom 
workers (Soyseth et al. 1997) and smelters (Johnsen et al. 2010) have identified an 
association between occupational exposure and an increased decline in lung function. 
Population studies, albeit not designed to study the relationship between occupational 
Background 
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exposure and obstructive pulmonary disease, have also shown this association 
(Humerfelt et al. 1993, Bakke, PS et al. 1991, Eagan et al. 2002). 
Exposure assessment in occupational epidemiology 
A major challenge in occupational epidemiology is accurate exposure assessments. 
Accurate assessment of exposure is essential to identify the hazards and to characterise 
the risks from low levels of exposure. Epidemiological studies that integrate 
quantitative exposure assessment are needed to provide new insights into the aetiology 
and mechanisms of action. 
Industry-based studies can frequently obtain detailed information on exposure, e.g. 
measurement data or semi-quantitative (low, medium, high) data whereas population-
based studies must often rely on qualitative exposure data (exposed vs. non-exposed). 
The industry-based studies can be retrospective or prospective. In retrospective studies, 
measurement data are often scarce, whereas in prospective studies, detailed information 
on exposure levels can be obtained.  
A quantitative exposure assessment strategy design can be based on two basic 
approaches. One approach focuses on individual workers, whereas the other approach 
focuses on groups of workers. The choice of an individual or a group based exposure 
assessment strategy depends on the purpose of the epidemiological study. For studying 
short-term effects (within one day or week), it is often possible to monitor all the 
relevant biological exposures on the individual level if relevant sampling equipment is 
available. In practice, during a long-term study period of months and years it is 
excessively time consuming and expensive and hence impossible to measure the 
exposures to each employee every day. For that reason, sampling is performed in 
restricted periods and distributed across study subjects and the study period (Rappaport 
1991). Workers should be chosen randomly and sampling should be performed on 
random days during the study period. Although the exposures of the individuals differ 
from the group average, the group average is assumed to reflect the exposure level for 
each worker. The error from measuring only a random sample of the workers in a group 
is compensated for by the increased precision from using all the measurements within 
the group to estimate the mean exposure (Nieuwenhuijsen 2003).  
The primary aim of exposure assessment in occupational epidemiological studies is to 
optimise the exposure estimate to detect a possible risk. Today, risks associated with 
Background 
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occupational exposure are generally small and to detect a risk when there is a genuine 
risk requires the exposure assessment to be very refined (Nieuwenhuijsen 2003). 
Quantitative measurements are preferred whenever possible.  
Video exposure monitoring 
Information on exposure levels or the time spent on various tasks can be used to 
improve exposure estimates in an epidemiological study and for identification of 
important determinants of exposure (Preller et al. 2004). This information can be useful 
in epidemiological studies in which peak exposures are hypothesised to influence the 
outcome. Video exposure monitoring (VEM, also known as PIMEX) combined with 
real-time monitors has been known since the mid-80s and has been used in task 
analyses for understanding and controlling exposure, in risk communication/motivation 
and for improvements in the work environment (Rosen et al. 2005). PIMEX is an 
established method that combines real-time monitoring instruments, typically for 
gases/vapours and dust, with video recording of the worker's activities (Rosen et al. 
2005, Rosen et al. 1989). The motivation for using PIMEX is that it provides detailed 
information of how different exposures vary with time and the ability to connect that 
variation directly to the work process, identifying the causes of variability in the 
exposures. 
Health related particle fraction 
An aerosol is a colloidal dispersion of solid or liquid particles in a gas, usually air. Dust 
is an aerosol of solid particles with sizes ranging from sub-μm to over 100 μm. Particles 
may have irregular shapes and behave differently depending on the shape and densities. 
To predict more effectively where particles deposit in the respiratory tract, the term 
“aerodynamic diameter, dae” was introduced to describe particle size (Hinds 1999). 
Particles that appear to have different physical sizes and shapes can have the identical 
aerodynamic diameter, and depending on their aerodynamic diameter the particles reach 
different part of the lungs (Vincent 1995). 
In 1993, “Workplace atmospheres. Size fraction definitions for measurement of 
airborne particles.” was published by the European Committee for Standardization 
(European Committee for Standardization (CEN) 1993). This standard defines the 
health-related aerosol fractions: 
Background 
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The inhalable fraction, which includes the thoracic and respirable fractions, is defined 
as the mass fraction of total airborne particles which is inhaled through the nose and/or 
mouth. 
The thoracic fraction, which includes the respirable fraction, is defined as the mass 
fraction that penetrates the respiratory system beyond the larynx. 
The respirable fraction is defined as the mass fraction that penetrates to the unciliated 
airways of the lung, known as the alveolar region, where the gas exchange takes place. 
Figure 1 shows that particles with an aerodynamic diameter larger than approximately 
10 μm cannot reach the alveolar region of the lung. 
Figure 1. Overview of aerosol sub-fraction according to EN 481 
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This standard can also be illustrated on this rudimentary drawing of the human 
respiratory tract (figure 2). 
Figure 2. Human respiratory tract and aerosol sub-fractions. Reproduced with permission from 
Vincent, Aerosol sampling © 2007, John Wiley and Sons. 
For obstructive chronic disease, the tracheobronchial fraction is thought to be the most 
appropriate fraction (Vincent 2005). There are no sampling devices that can measure 
this fraction. It can be deducted from the thoracic fraction minus the respirable fraction, 
but frequently the thoracic fraction is regarded the most relevant for this purpose. 
Exposures in the fertiliser industry 
Fertiliser production is a worldwide industry, and in the production process, workers 
may be exposed to aerosols, nitrous gases, ammonia, and acid aerosols. 
In the fertiliser industry nitrogen oxides derives predominantly from the production 
of/using nitric acid. Earlier studies have shown decreased lung function and increased 
airway inflammation in relation to nitrogen dioxide exposure with exposures as low as 
0.6-2 ppm, (Frampton et al. 2002, Frampton et al. 1991, Blomberg et al. 1997, 
Blomberg et al. 1999). In a study from Norway, Bakke et al suggested that temporary 
reduction in lung function might be explained by the observed peak exposures up to a 
maximum of 20 ppm to nitrogen dioxide (Bakke, B et al. 2001). 
Ammonia is produced on the premises, and thereafter used in the production of nitric 
acid and compound fertiliser. Ammonia exposure, in the range of 25-50 ppm, has been 
shown to irritate the upper airways in humans (Sundblad et al. 2004, Ballal et al. 1998). 
No effect on dynamic lung function was found at chronic occupational exposure to low 
levels of ammonia (9.2 ppm) (Holness et al. 1989) nor 50-140 ppm (Verberk 1977). 
Background 
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Rahman et al found that ammonia exposure was associated with respiratory symptoms 
and an acute decline in lung function (Rahman et al. 2007). The acute effects of high 
concentrations of ammonia may be fatal or lead to long-term impairment of respiratory 
symptoms (de la Hoz et al. 1996, Leduc et al. 1992, Flury et al. 1983).  
There are few studies on pulmonary effects of occupational exposure to the inorganic 
acids, and none of them reports any clear association (Gamble et al. 1984, Arnoldo et 
al. 2004, Koenig et al. 1994, Aris et al. 1993). 
Population studies from several countries have shown a higher prevalence of obstructive 
pulmonary disease among those reporting occupational exposure to dust and gases 
(Bakke, PS et al. 1991, Korn et al. 1987) Bergdahl et al found that occupational 
exposure increases mortality due to chronic obstructive pulmonary disease among 
construction workers (Bergdahl et al. 2004), and Kauffman et al found that the decline 
in FEV1 was significantly related to inhalation of mineral dust (Kauffmann et al. 1982). 
Previous studies on lung function in the fertiliser 
industry 
A literature search resulted in six papers which contained data on lung function among 
fertiliser workers. Some of the cross-sectional and cross-shift studies from various 
countries have shown reduced lung function and/or increased level of respiratory 
symptoms among workers in the fertiliser industry (Renke et al. 1987, Bhat et al. 1993, 
Geetha et al. 2001, Ballal et al. 1998, Ali et al. 2001, Rahman et al. 2007). 
Table 1 gives an overview of the studies. Five studies were cross-sectional studies, and 
one was a short-term follow-up study. A major weakness of many of these studies was 
limited exposure data. 
A limited number of epidemiological studies on cancer among fertiliser production 
workers have been published in the Scandinavian countries. Studies on possible 
associations between airborne nitrate and cancer have not shown an excess of gastric or 
lung cancer (Rafnsson et al. 1990, Hagmar et al. 1991, Fandrem et al. 1993). One of the 
studies was performed on the same site as ours and provides information on earlier 
exposure at this plant (Fandrem et al. 1993).
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Aim of the thesis 
The aim of this thesis was to investigate possible associations between occupational 
exposure, respiratory symptoms and change in lung function among the employees at a 
mineral fertiliser production plant. 
 
The following objectives were established: 
 
─ to investigate the decline of dynamic lung function and lung diffusing capacity 
during a three-year follow-up among the employees at a fertiliser production plant 
─ to characterise the present personal exposure to aerosols and gases among the 
employees at a mineral fertiliser production plant 
─ to study any association between respiratory symptoms and decline in lung function  
─ to study the correlation between nasal patency and dynamic lung function  
  
Historical background of mineral fertiliser production 
 20 
Historical background of mineral fertiliser production 
How the mineral fertiliser industry began in Norway 
On Friday, the 13th of February 1903, businessman Samuel Eyde and scientist Kristian 
Birkeland were invited for dinner by cabinet minister Gunnar Knudsen. During the dinner, 
Eyde told Birkeland about his studies on nitrogen and his purchase of the rights to certain 
waterfalls in Norway. He said: “What I want most is the most powerful electric flame on 
earth.” Birkeland replied: “I can provide that, Mr. Eyde.” This meeting is regarded as the 
beginning of the industrial fairytale of “Norsk Hydro”, formally established in 1905. 
Natural fertilisers have been used since the early days of agriculture. Various materials have 
been used; e.g. animal manure, seashells, vegetable waste, and ashes. At the beginning of 
the 20th century it was assumed that these supplies would not suffice for the growing 
demand for fertiliser. It was known that nitrogen should be in a form that could be absorbed 
by plants and that nitrogen was abundant in the atmosphere. The challenge was to find a 
way to transform large quantities of nitrogen at a reasonable cost. 
The Birkeland-Eyde process fixes atmospheric Nitrogen (N2) into nitric acid (HNO3) by 
having air blown through an electrical arc forming nitrogen monoxide (NO), which reacts 
with oxygen to yield nitrogen dioxide (NO2). Nitrogen dioxide is dissolved in water to yield 
nitric acid. The process is extremely energy intensive. Close proximity to electric energy 
was required, and the first two plants were built in Notodden and Rjukan (1905-11) where 
hydroelectric power was available. Electro technology made rapid progress and Norsk 
Hydro soon wanted to build a production plant on the coast. The island, Herøya, Porsgrunn, 
was flat and near natural deposits of limestone and with easy access to the sea, required for 
transporting raw material and final products. The island was bought in 1912, before the 
beginning of World War I. During the war the Haber-Bosch method was developed in 
Germany; it was a superior method for producing ammonia by converting nitrogen and 
hydrogen under pressure and at high temperature using reaction catalysts. In 1927, Norsk 
Hydro bought the license for building ammonia-producing plants modelled on the Haber-
Bosch method on Notodden and Rjukan, which meant that their product would be altered. 
On January 14th, 1928 Norsk Hydro announced they had chosen Herøya, Porsgrunn, as the 
site of their new plant. On February 1st, 1928, general director Aubert gave a lecture in 
Porsgrunn about the plans. During the dinner afterwards he said; “By the way, I forgot to say 
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that we start at Herøen tomorrow.” The next day, a line of people waited to get a job. On 
June 1st, 1929 the production began (Cartridge 2005).  
 
 
Photo. Production plant site – historical photos (courtesy of Hydro). 
In 1939 the director at Eidanger Salpeterfabrikk, Herøya, Tormod Gjestland, invited Dr. 
Eyvind Thiis-Evensen, Sr. to a meeting and asked him to work as a doctor at the factory. Dr. 
Thiis-Evensen started working part-time in 1940, but in 1941 the job became a full time 
position. The preventive medicine of today did not exist in the beginning of Norsk Hydro’s 
history, although health workers had been employed by the company from the 
establishment. The occupational health service worked and prospered for many years, and at 
the most 17 physicians were concurrently employed. There was at one time a ward with 20 
beds, and 100 persons could be treated for gas-induced injuries. Thiis-Evensen, Sr. was 
influential in establishing the first regional hospital department of occupational medicine in 
Norway, at Telemark County Hospital (St. Josephs Hospital, Porsgrunn). The majority of 
the studies from this period were in cancer epidemiology. The development of the 
occupational health service at Herøya, a significant element in the history of occupational 
medicine in Norway, is noteworthy as a background to this study (Thiis-Evensen, Sr 1985). 
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The fertiliser production process 
Fertiliser products differ according to raw materials and processes. Ammonia, nitric acid, 
apatite and potassium salts are the primary raw materials for the production of compound 
fertilisers. At the current plant the major product is compound fertiliser, containing varying 
ratios of two or three macronutrients, nitrogen (N), phosphorus (P), and potassium (K) and 
varying amounts of micronutrients. For the products containing magnesium and boron, 
kieserite and borax are used. At the current plant, the production runs by the nitrophosphate 
route. The complete industrial process is performed at the site (Kongshaug 1991). 
 
 
 Figure 3. Illustration of production process © Yara ASA 
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Principally, mineral dust, water-soluble and water-insoluble compounds, nitric acid (HNO3), 
nitrogen dioxide (NO2), nitrogen monoxide (NO), ammonia (NH3), and hydrogen fluoride 
(HF) may be released into the work environment in the various departments.  
In short, the process is based on the dissolution of phosphate rock in mineral acid followed 
by neutralisation, concentration, and granulation or prilling. 
The workers in the plants work shifts, and the production units run all year. Shift-work 
indicates working day, afternoon or night, including weekends. The majority of employees 
work in one department only. In all the departments, the employees have job rotations with 
some days in the control room only and other days working in the production area. When 
working in the production area the workers usually make assigned rounds that take from 30-
90 minutes. On the rounds, the workers conduct specific tasks such as quality control 
sampling and cleaning. Some of the tasks require more time, some are performed every day, 
and others at specified intervals. Table 2 provides a short overview of the production 
departments, possible exposures, and personal protection equipment. 
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Ammonia 
Ammonia is produced by the Haber–Bosch process which uses liquefied petroleum gas as 
the raw material. The following main steps are included in the process: 
x removal of sulphur compounds 
x primary and secondary reformer in which hydrogen and carbon monoxide is formed 
x shift conversion to convert carbon monoxide to carbon dioxide and hydrogen 
x absorption of carbon dioxide in water 
x methanation, if necessary, to remove even small residual amounts of carbon monoxide 
and carbon dioxide 
x finally the gas has the correct ratio of hydrogen and nitrogen and is compressed before 
the synthesis over a catalyst to ammonia 
3 H2 + N2 → 2 NH3 
Nitric acid 
Ammonia is converted to nitric acid by these main steps: 
x Ammonia evaporates and the gas is mixed with heated air; the oxidation, in the presence 
of a platinum catalyst, produce nitric oxide 
4 NH3 + 5 O2 → 4 NO + 6 H2O 
x Nitric oxide is oxidised to yield nitrogen dioxide. Nitrogen dioxide is readily absorbed 
in water at high pressure and low temperature, and nitric acid is formed (65%). 
Compound fertiliser 
Compound fertiliser contains nitrogen, phosphorus and potassium in various combinations. 
The main steps in producing compound fertiliser are the following: 
x Dissolution 
  Ca5F(PO4)3 + 10HNO3 → 3H3PO4 + 5Ca(NO3)2 + HF 
Varying amounts of nitrogen oxides (NOX), hydrogen fluoride (HF), and carbon dioxide 
(CO2) may be liberated. Urea is added at the outset to prevent the formation of NOX. 
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x Neutralisation. 
“Mother lye” (Moderlut), which now contains phosphoric acid, nitric acid, hydrofluoric 
acid, resolved Ca and Mg and low concentrations of contaminants, such as Fe, Al, and 
Si, and unresolved material (such as quartz), is cooled and calcium nitrate tetrahydrate 
crystallises out: 
H3PO4 + HNO3 + Ca(NO3)2 + 4 H2O → H3PO4 +  HNO3 + Ca(NO3)2 ∙ 4 H2O 
x Calcium nitrate is filtered and transferred to the calcium nitrate plant. 
x The solution of phosphoric acid, nitric acid and remaining calcium nitrate, called 
nitrophosphoric acid, is neutralised with ammonia.  
x Mixing and prilling. In the mixing process potassium/magnesium salts, sulphate and/or 
micro-nutrients, as specified for the product, are added. The final blend goes directly to 
the prill tower. 
x Cooling, screening, and coating 
Calcium nitrate 
x The calcium nitrate crystals are dissolved in ammonium nitrate solution and treated with 
ammonium carbonate solution: 
Ca(NO3)2 + (NH4)2CO3 → CaCO3 + 2 NH4NO3 
x The neutralised calcium nitrate melt is purified in decanter-centrifuges. Evaporation 
yields a higher concentration 
x Pan granulation. This solidification produces a salt composition of ammonium nitrate, 
calcium nitrate and water. 
x Cooling, screening and coating 
Shipping area 
The shipping area consists of locations for the unloading of raw material, storage and 
packing of final products, and the loading of final products. Coating of the final products is 
performed there, in a closed system. Contrary to work in the other departments, working in 
the control room in the shipping area includes checking the conveyor belts during the shift; 
other jobs include operating a crane, truck or dumper all day.
Materials and methods 
 27 
Materials and methods 
Study design and population 
This thesis is based on a longitudinal study on lung function indices, including self-reported 
respiratory symptoms, at a fertiliser production plant in Norway (Paper II and III). Within 
this study is an exposure study during follow-up (Paper I). Lung function was measured at 
two points, in 2007 and 2010. At baseline, nasal patency was also measured. Exposure 
measurements were performed over a one year period during 2007-08. A sub study on 
exposure assessment using video exposure monitoring, was performed during a week in 
May 2009. Both in 2007 and 2010, the employees answered a questionnaire on respiratory 
symptoms as well as smoking status (Appendix IV). In 2010, all the attendants answered a 
questionnaire on past work history and possible exposures, former short-term peak episodes, 
and use of personal protective equipment, with an emphasis on the follow-up period 
(Appendix V). 
All plant employees were invited to participate in the study (Appendices I and II). A total of 
406 persons were eligible in 2007, and 349 (86%) persons participated. Of the initial group, 
283 persons remained at work in 2010, of which 263 persons participated in the follow-up; 
34 employees participated in 2010 only. The total number of study participants was 383.  
There were various reasons for not participating, e.g. being on sick or maternity leave, being 
too busy at work, being absent from work on the day of examination, or choosing not to 
participate. The non-participants worked at all the different departments of the plant. The 
main reasons for leaving work after 2007, were retirement or moving to another job. 
All participants gave written informed consent on both occasions (Appendix III). The 
protocol was approved by the Regional Ethical Committee of South-East Norway and the 
Norwegian Data Inspectorate. 
Study variables 
Assessment of respiratory function 
Spirometry 
A bellow spirometer, Vitalograph 2160 (Vitalograph, Buckingham, England, using 
Spirotrac IV 4.32 for the data collection), was used in 2007 and 2010. The majority of 
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employees had previously performed spirometry tests at the occupational health service, but 
instructions about the procedure according to the American Thoracic Society/European 
Respiratory Society (ATS/ERS) 2005 criteria (Miller et al. 2005) were given before the 
subjects performed the test. The Vitalograph records the volume-time curve for a period of 
12 seconds on a chart, but the electronic reading of the machine records the expiratory 
volume for a maximum of 20 seconds. A detailed description of the spirometry test is 
described in Paper II. The surveys were performed at the same time of the year and by the 
same physician (Hovland). Reversibility testing using a beta-2-agonist was not considered 
feasible in this occupational setting and was not performed. Some tests not fully meeting the 
criteria were thought to still give valuable information (Miller et al. 2010, Becklake 1990) 
and were included after careful consideration. The spirometry test was performed on site, 
and the spirometer apparatus was moved among the various factories/offices. The 
spirometer was calibrated daily, and repeated calibration was performed if the temperature 
in the room rose by more than 2 degrees. When the instrument was moved, it was placed in 
the new position for a minimum of one hour before use (typically overnight) and calibrated 
before further use. 
Acceptability issues and exclusion criteria for spirometry tests 
The ATS/ERS criteria were followed (Miller et al. 2005). However, the data from some of 
the tests not fulfilling the criteria were included (Miller et al. 2010). The following list was 
used to categorise spirometry tests according to the quality check work. The given quality 
code index of each spirometry test was used to include or exclude the test during the 
statistical analysis. 
0 not approved 
1 everything OK 
2 unsatisfactory start of expiration 
3 the difference between the largest and the next largest FEV1 > 0.150 L 
4 the difference between the largest and the next largest FVC > 0.150 L 
5 did not meet the plateau criterion (<25 mL in one second) 
6 test < 6 second (accepted on the basis of the plateau criterion) 
7 accepted after consideration 
8 excluded FVC (but not FEV1) 
9 excluded FEV1 
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The tests not meeting the end-of-test criterion of the plateau criterion (<25 mL exhaled in 
the previous second of the blow) (N=193 of 649), and/or the two largest values of 
FVC/FEV1 not being within 0.150 L of each other (N=69) were included in the analysis. 
One spirometric result from 2007 and four results in 2010 were excluded from the study due 
to failure of a valid spirometry. In five cases, FVC results were not valid, although those for 
FEV1 were, and here only the FVC parameter was excluded. 
The single-breath lung diffusion capacity test 
The workers were instructed about the entire manoeuvre of the test before starting. 
Information on lung diffusing capacity is in Appendix VII, and the detailed procedure 
regarding measurement testing of lung diffusing capacity is described in Paper III. The 
identical Sensor Medics Vmax 22 model (CareFusion, Ca, USA) was used on both 
occasions. The results are expressed in SI unit mmol/min/kPa. All the measurements were 
performed according to the guidelines recommended by ATS/ERS 2005 (MacIntyre et al. 
2005) with the exception of the subjects standing instead of being seated. The technical 
construction of the apparatus required us to choose the standing instead of the sitting 
position for the subjects. All the tests were instructed by the same physician (Hovland). The 
gas mixture contained 0.3% CO, 0.3% methane (CH4), 0.3% acetylene (C2H2), 21% oxygen, 
and balance nitrogen. The instrument was calibrated daily during the study, using a 3 L 
syringe and the calibration gas (4% CO, 16% oxygen and balance nitrogen) (CareFusion, 
Ca, USA). The Jones and Meade breath hold time calculation method was used (Jones et 
al.). Patient dead space volume was set to 0.150 L, and the washout volume was 0.75 L. 
There was no adjusting for Hb, and no corrections were made for carbon monoxide back 
pressure by carboxyhaemoglobin (COHb), but the smoking status and last cigarette smoked 
were noted. 
Acceptability issues and exclusion criteria for lung diffusing capacity tests 
The ATS/ERS criteria were followed (MacIntyre et al. 2005). The following list was used to 
categorise the lung diffusing capacity results according to the quality check work. The given 
quality code index of each diffusing capacity test was used to include or exclude the test 
during the statistical analysis.  
0 not approved 
1 everything OK 
x Inspired volume >85% of FVC within 4 sec 
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x Two tests within 10% or 1 mmol/min/kPa 
x Breath Hold Time 10 ± 2 sec 
x expiration < 4 sec 
2 approved after consideration 
3 only one approved test 
4 inspiration > 4 sec 
5 exhalation > 4 sec 
6 Breath Hold Time higher or lower than 10 ± 2 sec 
7 two tests larger difference than 1 mmol/min/kPa or 10% 
8 test <85% of FVC 
9 one test <85% of FVC but DLCO within 1 mmol/min/kPa or 10% of the highest value 
C modified sample collection volume vs. machine 
S smoked less than 2 hours ago 
A “Extra air” 
V IVC (inspiratory vital capacity) > FVC 
X did not perform DLCO test, but had undergone spirometry 
If "normal" expiration at the beginning, but not full exhalation < 4 sec – code 1 was used. 
 
This method of coding all the manoeuvres yields a large variety of codes, e.g. 1: fully 
accepted; 1V: fully accepted, but one or both manoeuvres had IVC>FVC; 23: only one 
approved test, but included in the study; 26: breath hold time outside 10 ± 2 sec (one or both 
tests); 24SV: inspiration>4 sec, smoked less than 2 hours ago, IVC>FVC on one or both 
manoeuvres and so forth. In all the cases in which code 2 was used, whether the test should 
be included or not was thoroughly considered. Test quality outcomes for DLCO are shown in 
table 3. 
Table 3. Distribution of test quality outcomes for lung diffusion capacity tests  
Criterion Number of tests (%) 
0 39 (7.5) 
1 287 (55.5) 
2 191 (36.9) 
0 excluded 
1 accepted according to standardisation 
2 accepted after consideration  
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Table 4 gives an overview of the participants performing lung diffusion capacity test at the 
two times when the surveys were performed. A higher percentage was excluded in 2007 
than 2010. The primary reason is most likely that the test was new to most participants in 
2007, and thereby slightly difficult to perform. The majority of the excluded tests in 2007 
are because of excessively long breath hold time. A higher percentage did not participate 
with DLCO in 2010, mainly because of smoking prior to the test or no test performed in 
2007. The criterion of not smoking 2 hours prior to the test was more rigorously followed in 
2010. 
Table 4. Overview of participants at the two points of lung diffusing capacity testing 
Year No of tests Excluded Accepted DLCO test not performed (but spirometry) 
2007 308 37 271 41 
2010 209 2 207 92 
 
Two hundred (39%) of the tests showed IVC above FVC on one or both trials, and only 2 
persons had IVC< 85% FVC. (The criteria stated that inspiratory vital capacity should be 
>85% of largest vital capacity in < 4 seconds.) 
Questionnaires 
Respiratory symptoms 
A standardised, self-administered respiratory symptom questionnaire in Norwegian; an 
extended version based on the British Medical Research Council questionnaire (British 
Medical Research Committee 1960), was used initially and at the three-year follow-up 
survey (Appendix IV) (Paper II and III). The questionnaire was used to obtain information 
regarding respiratory symptoms, some previous illnesses, allergy, asthma, airway 
symptoms, and smoking habits. 
Work history  
The individual occupational history was taken at the survey in 2010 (Paper II and III). Each 
participant answered a questionnaire on the work place(s) and job tasks during the follow-
up, in addition to questions about former occupations and exposures (Appendix V). 
Occupational and non-occupational exposures known to possibly affect lung function were 
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asked for specifically, together with information on the use of personal protection 
equipment (PPE).  
Rhinometry 
Rhinometry is a non-invasive and easy method to measure nasal patency. Acoustic signals 
generated in a tubular probe are sent up the nasal passageway and reflected out in such a 
way that the procedure can accurately map out the topography of the nasal airway. The 
method is fast and without adverse effects. It has been found to provide a valid result at least 
for the first 5-6 cm of the nasal cavity (Hilberg 2002). A standardisation of the procedure 
was published in 2000 (Hilberg et al. 2000). Acoustic rhinometry (SRE Rhin2100, Rhino 
Scan version 2.6, Rhino Metrics AS, Denmark) was performed in 2007 with the subject in a 
seated position, using a handheld sound wave tube and an anatomical nasal adapter. The 
following variables were recorded: the second total minimum cross sectional area (MCA2) 
and volume (VOL2) previous of this deflection, measured at 22-52 mm from nostril, see 
photo below and figure 4. 
 
Photo. Performing rhinometry on a worker (private) 
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Figure 4. Example of an acoustic rhinometry profile 
 
Exposure assessment 
Sampling strategy for the epidemiological study 
All the production departments at a fertiliser plant in Norway were included in the exposure 
assessment (Paper I). Information on the production processes and job tasks in all the 
departments were obtained during several walk-through surveys at the plant before the 
exposure measurements were initiated. Included in these visits were interviews with 
workers and management. 
The selection of workers and day of the week were chosen randomly. The objective was that 
each participant carried sampling equipment for a minimum of two days. All the samples 
were collected outside personal protective respirators. The workers on duty in the control 
room on the day of measurement were excluded from the sampling as they are assumed to 
be unexposed when in the control room. This air sampling strategy makes it possible to 
estimate the exposure for all workers, including those not selected for participation in the 
exposure measurements, according to their affiliation with the groups that are subject to the 
measurement campaign and to assign group-based estimates of exposure to all the members 
of the group. 
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The thoracic fraction was used on the assumption that the exposure to the bronchial tree 
may reflect the outcome of obstructive lung function changes to a higher degree than other 
aerosol fractions. The inhalable fraction was included to provide information on the 
extrathoracic fraction. 
Personal air sampling methods and analyses 
The inhalable aerosol fraction was collected using the IOM (SKC Ltd., Blandford Forum, 
Dorset, UK) personal sampler at 2 L/min and the thoracic aerosol sub-fraction was collected 
using a BGI GK2.69 cyclone (BGI Inc., MA, USA) at 1.6 L/min. The thoracic aerosol 
fraction, inorganic gases, and acid vapours were collected simultaneously by placing two 37 
mm impregnated gas filter-pads (cellulose support pads) after the aerosol filter by inserting 
an extra ring into the standard three-part aerosol filter cassette (Millipore, MA, USA) (Paper 
I). The first filter-pad for collection of HNO3 vapour and HF was impregnated with 10% 
(w/v) potassium hydroxide (KOH) in H2O and dried at room-temperature for 24 hours. The 
second filter for the collection of NO2 was impregnated with 25% (w/v) sodium iodide 
(NaI) and 10% (v/v) ethylene glycol in methanol and also dried at room-temperature for 24 
hours. 
 
Photo. Preparing for personal exposure sampling. (private) 
 
The gases (NH3, NO2 and CO) were measured using PACIII (Dräger Aktiengesellschaft, 
Lübeck, Germany) gas sensors. A period of 30 seconds as the logging interval was selected. 
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The limit of detection (LOD) for CO, NH3 and NO2 was 2 ppm, 3 ppm, and 0.2 ppm, 
respectively. 
The gravimetric measurements of aerosol mass were performed for all the inhalable and 
thoracic filters. The chemical analyses included leaching of the water-soluble and the water-
insoluble aerosol fraction. The concentrations of Ca, K, Mg, and P in the water-soluble and 
water-insoluble aerosol fractions were determined with inductively coupled plasma optical 
emission spectrometry (Perkin-Elmer, Norwalk, CT, USA) and the concentrations of F−, 
NO2−, NO3−, PO43−and SO42− in the water-soluble aerosol fraction and leachates from the 
impregnated gas filter-pads were determined by ion chromatography (Dionex, Sunnyvale, 
CA, USA). A thorough description of the analyses and quality control is given in Paper I. 
Video exposure monitoring of short-term peak episodes 
Based on the data collected in the exposure assessment study (Paper I), with the workers 
experiencing short-term peak episodes, a sub study using PIMEX was initiated to further 
identify the variability of the exposure. 
PIMEX2008, with telemetry equipment for wireless transmission of the monitoring signal 
was used. Workers at the compound fertiliser departments, the calcium nitrate department 
and the shipping area participated during one week in May 2009. Only those working in the 
production area on the day of sampling were selected, and the workers were followed on 
their regular rounds. The measurements started just before leaving the control room and 
ended when the worker returned to the control room. The worker carried a direct reading 
aerosol spectrometer (DustTrak aerosol monitor 8520, TSI, MN, USA) and NH3 and NO2 
gas sensors (PACIII, Dräger Aktiengesellschaft, Lübeck, Germany). One investigator 
carried the video camera making sure the worker was always in the picture and another 
investigator carried the laptop computer. The signals from the DustTrak™ were 
synchronised with the video during the measurements, while the monitoring signals of the 
gases were manually synchronised afterwards. 
The participants were selected to cover as many of the work tasks as possible for that 
department. A total of 20 rounds were performed using PIMEX strategies. The rounds were 
allocated as follows; Compound Fertiliser A, two rounds; Compound Fertiliser B, six 
rounds; Compound Fertiliser C, eight rounds; Calcium Nitrate, two rounds; and the shipping 
area, two rounds. 
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Statistical analysis  
Repeated observations were available for 69% of the employees for the spirometric data and 
for 55% for the gas diffusion data, and a longitudinal mixed model approach was used to 
study change in lung function indices among the employees from 2007 to 2010 (Papers II 
and III). The main objective of the thesis was to study the effect of exposures to aerosol and 
gases on the decline in lung function. Because many of the personal air measurements of the 
agents that were included in the exposure assessment were below LOD, it was not feasible 
to calculate quantitative exposure estimates for each worker of the cohort. In the 
epidemiological analyses (Paper II and III) workers were therefore assigned to a job group 
based on the information on where they had worked during follow-up. Information on 
department was obtained from company records and compared to self reports from the 
questionnaires. Study participants tested only once were grouped in the department they 
served on the day of lung function testing. The employees not working in the production 
area, including those who reported < 2 hours on average per week in the production areas, 
were assigned to the group “Other” yielding eight job-groups in the epidemiological 
analyses. No reference group was used studying the longitudinal data, as the subjects serve 
as their own controls. Adjustments were made for gender, age, height, weight, smoking 
status, and doctor diagnosed asthma. 
The absolute effects of each job group were reported. The adjusted decline was also 
considered for all workers without regards to job group. Furthermore, the effect of the 
number of years worked at the fertiliser plant had on the change in the lung function was 
analysed. 
The mixed model analysis use actual age at years 2007 and 2010 and not the baseline 
values. This means that the age related decline is estimated through age only, and also that 
the exposure (job group) related decline is not influenced by age. To summarize, the 
estimated decline in lung function for a particular job group, is the decline that exceeds what 
is expected due to age for a person with a particular gender, height, weight, smoking and 
asthma status. 
A mixed model includes both fixed and random effects. Fixed effects models the systematic 
effects of covariates as age and gender, while random effects models the dependency 
structure of data. Our model takes into account the dependency of the repeated observations 
by adding random effects for workers. The mixed model can be represented formally as 
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୧୨ ൌ ୧୨୘Ⱦ ൅ ୧ ൅ ɂ୧୨, where ୧୨ is the observed pulmonary function of person i and 
replication j, and ୧୨୘ is a vector of regressors linking the observations to the fixed effects β. 
Furthermore, ୧ represents independent and identically distributed normal random effects 
with a mean 0 and varianceɐ୳ଶ, while ɂ୧୨are independent and identically distributed normal 
random variables with a mean 0 and variance ɐகଶ. Different variance structures were 
compared using likelihood ratio tests, and based on these ɐகଶ was allowed to differ for the 
two genders. 
The self-reported symptoms were analysed by McNemar's chi-squared test with continuity 
correction (Paper II and III). 
The reference equations of ECSC (Quanjer et al. 1993, Cotes et al. 1993) and Gulsvik 
(Gulsvik 1979, Gulsvik et al. 1992) were used for baseline characteristics. When analysing 
the relation between changes in FEV1 % predicted and DLCO % predicted during follow-up, 
the ECSC reference equations were used. 
Data on possible correlation between rhinometry and FEV1 % predicted (Quanjer et al. 
1993) were tested using a test statistic of Pearson's correlation that follows a Student's t-
distribution. 
In the exposure assessment (Paper I) only workers in the production areas were included as 
those having control-room and administration duties on the day of measurement were 
assumed to be unexposed. All the production departments (ammonia, nitric acid, compound 
fertiliser (3 departments), and calcium nitrate) and the shipping area were included. The 
exposure data (Paper I) were found to be best described by lognormal distributions. The 
standard measures of central tendency and distributions by AM, geometric mean (GM), and 
geometric standard deviation (GSD) was calculated using the maximum likelihood 
estimation, since many observations were below the limit of detection. The within- and 
between-worker variances were calculated using a mixed effect model. The significance of 
the differences in exposure levels among the departments was evaluated using ANOVA 
analysis with Bonferroni correction for multiple comparisons.  
Linear mixed models and maximum likelihood models were analysed in R (http://www.r-
project.org) and all other data analyses were performed with R or SPSS v 15.0 for Windows 
(SPSS, Chicago, Illinois, USA).
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Results  
Lung function indices 
For the total group, there was an adjusted decrease of FEV1 of 18 mL/yr (p<0.001), but no 
statistically significant decrease of FVC during the follow-up period (Paper II). This finding 
provides an estimate of the lung function changes not explained by gender, age, height, 
weight, smoking status, and doctor-diagnosed asthma. Studying the various job groups a 
statistically significant annual decrease in FVC (48 mL/yr, p=0.0023) and in FEV1 (33 
mL/yr, p=0.012) was found among the workers in the nitric acid job group. The adjusted 
annual change in FEV1 varied between -33 to11 mL per year among the job groups. The 
subjects in one job group, compound fertiliser B, had a statistically significant increase in 
FVC. 
Regarding DLCO, an adjusted, statistically significant decline of 0.068 mmol/min/kPa/year 
(p<0.01) was found for the entire group during the three-year follow-up (Paper III). The 
change in DLCO varied from -0.15 to 0.12 mmol/kPa/min between the job groups. Only the 
job group “Other” showed a statistically significant decline in DLCO (p=0.004). In a sub-
analysis, excluding those who had smoked within 2 hours prior to testing in 2007 because of 
the stricter regulation of this criterion in 2010, did not change the results significantly 
(results not shown). 
At baseline a highly significant, but weak, correlation between the percent predicted DLCO 
and the percent predicted FEV1 was found (r=0.25, p<0.0001). No correlation between 
change in FEV1 % predicted and change in DLCO % predicted during follow-up was 
established (results not shown). 
 
Respiratory symptoms 
No statistical significant association between selected self-reported lung symptoms; 
morning cough, cough with phlegm, cough with phlegm more than three months/year, and 
wheezing, and decline in lung function was found (Paper II and III). Studying the change 
from 2007 to 2010, a statistical significant increase in the prevalence of “morning cough” 
from 8.0% to 13.6% was observed (p<0.01). None of the other symptoms studied showed 
statistically significant changes (Paper II). 
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In Paper II it is shown in Table 1 that smokers had lower FVC percent predicted and FEV1 
percent predicted than non-smokers at baseline. Looking at percent predicted by symptoms 
at baseline a similar trend is seen, with those reporting selected symptoms having a lower 
percent predicted of both FVC and FEV1 than those not reporting symptoms, as shown in 
table 5. 
Table 5. Dynamic lung function in percent predicted1 at baseline by different symptoms and gender 
 All 
No 
symptoms Wheezing 
Morning 
cough 
Daily cough 
w/phlegm 
Cough w/phlegm 
>3 months/yr 
 %pred(N) %pred(N) %pred(N) %pred(N) %pred(N) %pred(N) 
FVC male 99 (308) 102 (216) 93 (78) 91 (29) 92 (24) 94 (25) 
FEV1male 93 (311) 96 (218) 84 (79) 79 (29) 81 (24) 83 (25) 
FVC female 112 (33) 112 (26) 110 (5) 0 112 (1) 110 (2) 
FEV1female 103 (33) 104 (26) 95 (5) 0 111 (1) 108 (2) 
1 ECSC reference equation 
 
Rhinometry 
In 2007, rhinometry was performed before the lung function testing (Hovland 2008). No 
congestion nasal spray was used because of possible interaction with lung function testing. 
The nasal patency was compared to dynamic lung function, and a borderline significance 
was found on correlation between VOL2 and FEV1 % predicted using ECSC reference 
equation (Quanjer et al. 1993) (p=0.047) but no significant results were obtained using 
Gulsvik reference equations (p=0.074) (Gulsvik 1979) (figure 5). 
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Figure 5. Correlation between rhinometry volume (VOL2) and FEV1%predicted (ECSC reference 
equation) 
Exposure assessment 
In total, 178 inhalable and 179 thoracic personal aerosol mass fraction samples were 
collected from randomly chosen workers (N=141), on random days, from all the production 
departments; three compound fertiliser departments, a calcium nitrate fertiliser production 
department, nitric acid- and ammonia-production departments, and a shipping department 
(Paper I). The sampling time varied between 195-455 minutes (the arithmetic mean (AM) = 
365 minutes). 
The median inhalable and thoracic aerosol mass concentrations were 1.1 mg/m3 (min-max: 
<0.93 - 45) and 0.21 mg/m3 (min-max: <0.085 - 11), respectively. Studying the job groups, 
workers at the Compound Fertiliser departments B and C were exposed to significantly 
higher inhalable aerosol mass air concentrations compared to the other departments 
(p<0.05) except the Compound Fertiliser department A. The difference between the 
Compound Fertiliser department C and the Calcium Nitrate department was slightly above 
the significance level. The workers at Compound Fertiliser department A had significantly 
higher thoracic aerosol mass air concentrations compared to the other departments (p<0.05), 
except for Compound Fertiliser departments B and C. 
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Figure 6 and Figure 7 shows box-plots of the inhalable and thoracic aerosol mass air 
concentrations for the various departments. 
 
Figure 6. Inhalable aerosol mass air concentration for the departments 
 
Figure 7. Thoracic aerosol mass air concentration for the departments 
The measurements indicate that the extrathoracic aerosol fraction of the aerosol compared to 
the thoracic fraction dominated in most departments, varying from 57% to 92%. A shift 
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towards more water-soluble species as the production goes from the raw material stage with 
phosphate rock towards the final fertiliser products was found.  
The air concentrations of the major constituents Ca, K, Mg, and P, in the water-soluble and 
water-insoluble aerosol mass fractions were low. The highest median levels in the water-
soluble fraction were; Ca: 85 μg/m3 in Compound fertiliser A, K: 270 μg/m3 in Compound 
fertiliser C, Mg: 16 μg/m3 in Compound fertiliser B, and P: 17 μg/m3 in Compound fertiliser 
B and C, The highest median levels in the water-insoluble fraction were; Ca: 140 μg/m3 in 
Compound fertiliser A, K: 7.6 μg/m3 in Compound fertiliser C, Mg: 31 μg/m3 in Compound 
fertiliser C, and P: 40 μg/m3 in Compound fertiliser B. All the constituents are in a neutral 
form, i.e. not alkaline as in the cement industry. There are no Norwegian OEL’s for the 
constituents.  
Overall, the median air concentrations of CO, NH3, and NO2 measured using the PACIII 
direct reading instrument were below the LODs (2 ppm, 3 ppm, and 0.2 ppm, respectively) 
for the different gases. Short-term peak episodes were observed performing specific tasks as 
cleaning or quality control sampling. Regarding CO, all the measurements had median 
values below LOD and no peaks above the Norwegian OEL (25 ppm) were measured. As 
for NH3, 59 out of 60 measurements had median values <LOD and 10 measurements had 
max values > 25 ppm (Norwegian OEL) (logging interval 30 sec). For NO2, all 
measurements had median values below LOD and 11 measurements had max values > 0.6 
ppm (Norwegian OEL) (logging interval 30 sec). Quality control sampling in the nitric acid 
department is shown in the photo below. An overview of all the peak episodes for NH3 and 
NO2 with values above Norwegian OEL is presented in tables 6 and 7, followed by figures 
from two of the measurements (figures 8 and 9). 
 
Photo. Worker performing quality control sampling in the nitric acid department
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Figure 8. Direct read measurement of ammonia concentrations in Compound fertiliser B dept 
 
 
Figure 9. Direct read measurement of nitrogen dioxide concentrations in the Nitric acid dept
Time 
Time 
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Video exposure monitoring of short-term peak episodes 
The sub study using PIMEX confirmed the results in the exposure assessment study (Paper 
I) with short-term peak episodes when performing certain tasks like quality control 
sampling, cleaning, or inspections, and the specific tasks with short-term peak episodes 
were identified. Although time weighted averages of most exposures were legally 
acceptable, the video demonstrated high transient personal dust and gas exposure. The 
information could be used to assist in the reduction of personal exposures in the selected 
departments. 
Information from such videotapes could be used to develop checklists of determinants that 
may affect exposure and to correlate behaviour and exposure level. Furthermore, this 
method could be used to develop questionnaires for epidemiological studies. However, for 
the latter purpose the number of representative measurements must be sufficient. The 
identification of behaviour-related factors in epidemiological studies may explain variation 
in disease risk of individuals. 
The results were presented to the involved worker and foreman right after the round using 
PIMEX.  
 
Photo. Video exposure monitoring in a department 
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Discussion 
This thesis encompasses a three-year prospective cohort study on lung function including 
self-reported respiratory symptoms, as well as an exposure assessment study performed over 
one year during the follow-up time, among employees at a fertiliser production plant in 
Norway. The exposure assessment is accounted for in Paper I. The results on dynamic lung 
function (FVC and FEV1) and respiratory symptoms are presented in Paper II and those on 
lung diffusing capacity (DLCO) and respiratory symptoms in Paper III. 
Methodological considerations 
Study design 
A major advantage of a longitudinal study, as opposed to a cross-sectional study, is the 
possibility of examining the effects of exposure on changes in the health outcome with 
greater accuracy since the individuals serves as their own controls and hence between-
worker variation is removed (Fitzmaurice et al. 2004). Furthermore, a longitudinal study is 
robust to baseline differences and dropout mechanisms that are missing at random (MAR). 
A prospective longitudinal study gives more reliable information on a possible relation 
between current exposures and health effects. The exposure must precede the outcome in 
time to describe such a possible causal relation. This relation is best suited for studies in 
which the health outcomes occur within a relatively short time period (Checkoway et al. 
2004). The longitudinal design in a study thus may provide information on causation if the 
follow-up period is within the recommended time (Bakke, PS et al. 2011). Three years is, 
however, considered to be sufficient to detect rapid decliners. Another prerequisite is that 
the exposure is high enough to provoke the health outcome being studied.  
The limitations of prospective cohort studies include the time consumed and expenses. The 
loss to follow-up and the fact that longitudinal studies are susceptible to survivor bias 
should be considered (Eisen et al. 1995, Bakke, PS et al. 2011). The validity of the results 
may be questioned if the proportion of those lost to follow-up is large, i.e. 30-40%. In cases 
in which there are strong reasons to believe that the dropout may be related to the 
unobserved outcome at the follow-up, i.e. when the dropout is not missing at random, a 
lower percentage of lost to follow-up subjects can also be of concern. In this study the 
number of lost study participants during the follow-up is considered to be acceptable (25%). 
It cannot be excluded that some were lost due to outcome.  
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Figure 10 shows a comparison of FEV1 % predicted for dropouts and non-dropouts by age 
(Quanjer et al. 1993). This shows that dropouts were distributed over the whole age span 
and with various FEV1 % predicted values. 
 
 
Figure 10. Baseline FEV1 % predicted (ECSC reference equation) by dropout status and age.  
        Dropouts, blue. Non-dropouts, red. 
 
 
The two sample t-tests for inequality shows no significant difference between the baselines 
FVC % predicted and FEV1 % predicted observation for dropouts and non-dropouts (table 
8). 
Table 8. Baseline FVC % predicted and FEV1 % predicted for dropouts and non-dropouts 
 FVC % preda FEV1 % preda 
 Mean (SD) Mean (SD) 
Dropouts (n=86) 98.6 (16.0)b 92.0 (19.3)b 
Non-dropouts (n=263) 101.2 (13.7) 94.6 (15.7) 
a ECSC reference equation 
b two-sample t-test, p>0.05 
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Spirometry and gas diffusion techniques are well-known and much used both in the clinic 
and in epidemiological studies. Measurements of FVC, FEV1, and DLCO are simple and 
reliable, but it is important to follow standard procedures (Miller et al. 2005, Miller et al. 
2005, Pellegrino et al. 2005, MacIntyre et al. 2005). The standard procedures are made with 
a healthy person in mind and, e.g. subjects with pulmonary obstruction will not be able to 
fulfil the criteria. Kellie et al showed that those with respiratory symptoms more often failed 
to fulfil the spirometry criteria than asymptomatic persons (Kellie et al. 1987). Exclusion of 
subjects not meeting the criteria may introduce a bias. Both the spirometric and the gas 
diffusion test results were quality checked by the same physician (Hovland) and some tests 
were included although not fully meeting the criteria (Paper II and Paper III) (Miller et al. 
2010). 
Both the questionnaires were self-reported. The employees got the questionnaires at work 
and a group influence, if it were filled out together, is possible. There is no indication of 
group influence in the replies of the employees. 
Rhinometry 
Nasal patency was measured using a rhinometry in 2007. The instrument is simple in use. 
The main reasons to measurement errors are leakage around the nostrils, too high 
background noise, or temperature variation (Djupesland et al. 1998, Hilberg et al. 2000).  
Sampling strategy of exposure assessment 
The purpose of the sampling strategy used in this study is to provide representative exposure 
data, i.e. data about exposure at the group level. The exposure measurements were 
performed over one year (Paper I) as suggested by Rappaport et al and Spengler et al 
(Rappaport et al. 1995, Spengler et al. 1994), during the three-year period of the study. The 
exposure of dust and gases to each operator varies during the working day, from day to day, 
with the weather and seasons, and with changes in the process, the raw materials, and the 
tasks performed (Nieuwenhuijsen et al. 1995, Cherrie 1996). In practice, during a long-term 
study period, it is excessively time consuming and expensive and, therefore, impossible to 
measure the exposures to each operator every day. When assessing long-term exposure 
levels, sampling typically will be performed during a defined period and the mean of the 
exposure measurements within the group is assigned to each worker in the group.  
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The strength of this study is the personal exposure measurements being performed from 
April 2007 till July 2008. In total, 141 workers (of 270 eligible) carried sampling equipment 
and 23% were monitored on more than one occasion. The workers selected for the exposure 
assessment were randomly chosen and all voluntarily agreed to participate. Only the 
workers who were scheduled to have rounds in the production area on the day of the 
sampling were selected and the various rounds were included throughout the sampling 
period. The workers participating in the exposure study were hypothesised to be 
representative of all the workers in the company (Paper I). 
Among the first to describe a strategy with sampling performed on random workers and 
random days were Corn and Esmen in 1979 (Corn et al. 1979). Corn and Esmen introduced 
the concept “working zone”, where workers within the same “zones” were assumed to be 
similarly exposed. The “zones” were qualitatively judged based on work similarity; e.g. 
having the same job title/carrying out similar work, similarity to particular substances, or 
similarity of environmental conditions. Even though the exposure of the individual differs 
from the group average, the group average is assumed to reflect the exposure level for each 
worker. The error from measuring only a random sample of the workers in a group is 
compensated by the increased precision from using all the measurements within the group to 
estimate mean exposure.  
Earlier studies have shown that exposure measurements would be more correct if the 
workers used personal sampling equipment (as opposed to stationary measurements), as is 
done in our study, even with awareness of the between-worker and within-worker variability 
(Rappaport 1991, Cherrie 2003). In cases in which the variability between the workers in a 
group is large, the variability will lower the precision of exposure-response relationships in 
epidemiological studies when the analysis is based on group mean exposure levels 
(Rappaport et al. 1995). The percentages of the total variance explained by department 
(fixed effect) for inhalable and thoracic mass fractions were 28% and 51%, respectively 
(Paper I). The within-worker variance was larger than the between-worker variance for the 
inhalable mass air concentration whereas it was equal for the thoracic mass air concentration 
(Paper I).  
Selection bias and loss to follow-up 
Selection bias occurs when the procedures used to select the subjects or factors that 
influence study participation lead to a distorted selection so that that the participants are not 
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representative of the employees within the company (internal) or for the trade (external) 
with respect to exposure and outcome. In this study, only persons working at the particular 
plant of interest were invited. This design excludes the conclusions to pertain to people 
outside that population – the external validity or generalisability is low (Rothman 2002). 
One can argue, though, that external validity exists for people working in the same type of 
industry if one knows that the exposure is of similar magnitude – it is generalisable to 
relevant target populations. 
At the plant under study, all the workers were invited, and the participation rate at inclusion 
was 86%. At follow-up, only 20 persons who remained at the plant and who had 
participated at baseline did not participate in the follow-up. The reasons for not participating 
were various at both times, but seemed not to depend on lung function or exposure. 
Therefore, the participants are considered to be representative for the cohort. 
A well-known problem regarding occupational studies is the healthy-hire and healthy-
worker effects (Olivieri et al. 2010, Arrighi et al. 1994). Subjects with respiratory problems 
are less likely to enter jobs involving inhalation exposures (Olivieri et al. 2010). The 
healthy-worker effect indicates that healthy individuals remain employed and those who 
experience work-related symptoms leave that job. Symptomatic workers may also avoid 
exposure situations and/or be more cautious in using personal protection. 
Another possible bias is left-truncation. This bias occurs when workers hired prior to the 
start of follow-up (baseline) and still working at baseline are followed up (Applebaum et al. 
2011). These workers have then already undergone a pre-selection, e.g. through a healthy-
hire effect. This is confirmed by the fact that cross-sectional studies have been found to over 
represent healthier workers (Checkoway et al. 2004). Ideally, all workers should have been 
followed since starting working at the plant. The terms cross-sectional cohort (Weiss 1983) 
and cross-sectional-follow-up (Koskela et al. 1984) have been used to describe a cohort 
entirely consisting of workers identified at one point in time, i.e. baseline of a study and 
followed forward. Workers hired before the start of our study may introduce downward bias 
in exposure-response estimates for null and positive associations. The bias increases with 
time as the workers who remain at work comprise a larger portion of non-susceptible 
workers compared to those who have left the work place. Individual changes in lung 
function during follow-up were studied, and the design is more robust to this type of pre-
selection bias. If survivor bias is present here, one would expect it to lead to a smaller lung 
function decline during follow-up. 
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A more rigorous selection strategy in 2010 excluding those having smoked within 2 hours 
before the test, might have led to a bias regarding DLCO in the analysis. Because there are 
some observations included in 2007 of those who had smoked less than 2 hours prior to 
testing, then a removal of those might lead to a higher expected decline in DLCO. To retain 
the results from these individuals from 2007 will be conservative; the analysis gives an 
expected lower rate than the actual fall. It may be an argument for removing these 
observations if smoke <2 hours before test is considered to affect DLCO significantly. Using 
the identical criteria in 2007 and 2010 no bias in the analysis was found. 
As regards the exposure assessment, a selection bias could be introduced if only some 
workers accepted to participate, and if those denying participation are, as a group, different 
from those accepting to participate. All the workers that were requested to participate in the 
exposure sampling volunteered to do so; hence, a bias in the selection of workers 
participating in the exposure assessment is not considered. 
Information bias 
Information bias refers to whether those included in the study are misclassified with respect 
to outcome or exposure status (Checkoway et al. 2004). In this study, the outcome was 
change in the lung function indices and is not considered to be subject to information bias. 
The questionnaires on respiratory symptoms can introduce information bias, as those being 
ill of chronic obstructive pulmonary disease tend to report more symptoms than those not 
having disease (Bakke, PS et al. 2001). Earlier studies have shown that doctor-diagnosed 
asthma has a high specificity but low sensitivity (Kongerud et al. 1989, Toren et al. 1993). 
A greater sensitivity towards occupational exposure due to the focus on a survey might 
influence toward an increase in positive replies (Samet 1978). Bakke et al comment in their 
study that exposed subjects might over report respiratory symptoms (Bakke, PS et al. 2001). 
Being three years apart the symptoms may both develop and remit, but the attendants are 
not likely to recall their former answers and hence bias the results. There seems to be no 
over-reporting of symptoms. 
Exposure misclassification could occur. With the quantitative, group based exposure 
assessment of randomly selected workers, as chosen in this study, the exposure 
misclassification is considered to be non-differential (Blair et al. 2007). 
During the study period the Compound Fertiliser departments and the Calcium Nitrate 
department were partly reorganised. Few workers were reassigned to other job groups. 
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Differential misclassification may occur if exposure classification is related to the outcome 
status. If those with low lung function had been moved to less exposed work, and located to 
the group “Other” in our study, any true relation between exposed groups and the lung 
function may be masked. Analysing the lung function in the various job groups, there was 
no indication of such a bias in the job-group “Other”. 
Measurement errors 
Measurement errors imply the difference between the estimated group mean decline in lung 
function and the true group mean decline. This phenomenon can be minimised by increasing 
the number of subjects, the years of follow-up, or the frequency of measurements 
(Schlesselman 1973, Berry 1974, Wang et al. 2000). Berry used single values of the 
between- and within-subject variation for different combinations of study duration and 
measurement frequency to estimate the accuracy of a study (Wang et al. 2000, Berry 1974). 
There were a between-subject standard deviation of 0.539 L/year and a within-subject 
standard deviation of 0.126 L/year in the data in this study.  
Clement and Van De Woestijne argues for a minimum of six to eight years of follow-up to 
appreciate with precision the rates of decline in lung function in their study among members 
in the Belgian Air Force (Clement et al. 1982). In 2011, the ERS published a task force 
report; “Recommendations for epidemiological studies on COPD” (Bakke, PS et al. 2011) 
aimed at general population studies, but also valuable in the occupational setting. A 
minimum time of 3 years of follow-up for FEV1 assessment is recommended, as in this 
study. Statistically there is no difference in having three measurements compared to two 
(Schlesselman 1973). 
Lung function testing procedures 
The spirometer used in this study was the same Vitalograph instrument at both surveys. 
Also, the same lung diffusing capacity equipment was used throughout the study. The major 
objective was to follow the change in lung function indices during a three-year period and 
using the same instruments minimises bias compared to using different instruments. 
One criterion for a valid DLCO test is that inspiratory vital capacity (IVC) should be a 
minimum of 85% of vital capacity. Only two participants had IVC < 85% of FVC, and 131 
had IVC>FVC. This finding is contradictory to that found in many population studies 
(Welle et al. 1998, Viegi et al. 2001). This result could be due to the study participants in 
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our study standing when performing the gas diffusion manoeuvre instead of being seated, 
which is the case in most comparable studies. Also, different instruments may yield 
different results. Johannessen (Johannessen 2007) compared FVC, FEV1, and FEV1/FVC 
for the Gould spirometer and the Vitalograph spirometer and found that FVC and FEV1 
were lower with the Vitalograph than with the Gould spirometer. Because the manoeuvres 
were performed with the same instruments at both surveys and the dynamic and diffusing 
capacity tests were not compared, this factor should not imply any bias. 
The same qualified physician instructed the dynamic lung function and diffusing capacity 
tests at both surveys reducing variance due to several investigators. The quality control and 
calibration were performed throughout the surveys (Miller et al. 2005). 
Respiratory symptoms questionnaire 
Respiratory symptoms questionnaires have been used extensively throughout the years. In 
the 1950’s the Medical Research Council (MRC) of Great Britain recognized the need for a 
uniform terminology and methods so that results of prevalence surveys on chronic 
bronchitis were to be compared and prospective studies could describe accurately the 
natural history of disease (Samet 1978). The MRC questionnaire on respiratory symptoms 
was first published in 1960 and has been revised thereafter (British Medical Research 
Committee 1960). It has been translated into many languages and modified many times. 
Especially questions being more specific about asthma has been added, like e.g. wheezing 
(Toren et al. 1993). 
Validity and reliability are both general problems with questionnaires. Validity refers to the 
questionnaire’s ability to measure which it was designed to measure (Samet 1978, Toren et 
al. 1993). As for validity one also has to understand sensitivity and specificity; sensitivity 
measures the proportion of true positives correctly identified as positive whereas specificity 
measures the true negatives as negative. To estimate the validity one needs a “truth/gold-
standard”. Reliability/repeatability can be tested by having the same individuals answering 
the questionnaire twice. However, to test this, the questions have to be “hold” questions; i.e. 
questions where the answer should be the same regardless of the time between the tests. 
Questionnaire responses can change with time, e.g. long-term changes like in our study, can 
be caused due to change in illness/symptoms whereas short-term changes are more likely to 
be due to the variability inherent in answering questionnaires (Brogger et al. 2000).  
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In this study, a questionnaire on respiratory illnesses and symptoms including smoking 
history was used at both occasions of data collection. The majority of the workers had filled 
in the questionnaires before the lung function testing. After the first round in 2007, it was 
apparent that the questionnaire was not optimal for our use, although it was a modified 
validated questionnaire (Kongerud et al. 1989) based on the MRC questionnaire (British 
Medical Research Committee 1960), translated into Norwegian and used before in an 
industrial setting (Kongerud et al. 1990). It turned out that not all the information gathered 
could be used. As for the questions on respiratory symptoms, the questions on cough and 
cough with phlegm are not related to any specific time, thereby limiting the knowledge on 
whether the answer is on acute or chronic symptoms. Time has passed since the validation 
was conducted and some illnesses are “out of date” and not familiar to everyone, e.g. 
tuberculosis or lung fibrosis. In addition, one question was particularly misleading to the 
participants: “Did you any time, during the last 12 months, experience attacks of 
breathlessness after completing physical exercising?” (Personal translation from the applied 
questionnaire) The ECRHS uses the wording: “Have you had an attack of shortness of 
breath that came on following strenuous activity at any time in the last 12 months?” First, 
the question includes two questions; “do you exercise?” and “do you experience attacks of 
breathlessness after completing physical exercising?” Second, many of the workers exercise 
regularly and experience breathlessness – on purpose – after the session. Using another 
questionnaire could have introduced bias because small changes in the phrasing of a 
question can have effects on prevalence estimates (Brogger et al. 2000, Ekerljung et al. 
2013). The advantages of using the same questionnaire were found to be superior to the 
disadvantages of using two different questionnaires. 
Holland et al found that season may influence symptom prevalence, with a higher 
prevalence in the winter (Holland et al. 1969). The examinations were performed at the 
same time of the year, so this should not influence any change between the two samplings. 
Nevertheless, the winter of 2010 was colder than the one in 2007, and the employees 
answered the question on respiratory symptoms in general and not particularly related to 
working hours. Asthmatic persons can react to cold weather with more symptoms (Hyrkas 
et al. 2014). However, the questionnaire was not designed to study this. The observed 
increase in morning cough from 2007 to 2010 is difficult to interpret due to the low number 
of persons reporting the symptom. 
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Questionnaire on work history  
An exposure assessment was conducted during the study period, thus the questionnaire on 
exposure was not used in our study as a proxy for exposure. The questionnaire included 
questions on work-related activities during follow-up, possible exposures the workers could 
have been exposed to previously in their work at the plant, the amount of time spent in 
exposed areas during the follow-up period, and the use of personal protective equipment 
(PPE) (Appendix V) The information provided on this questionnaire confirms where the 
workers were assigned during follow-up and how much time they spent working in the 
production areas versus the control room. It is known that personal information on the use 
of PPE can be inadequate. Because of the generally low levels of exposure it was not 
feasible to further refine the exposure levels, and possible inadequate information on the 
time spent in the production areas and the use of PPE therefore could not influence the 
results. 
Exposure measurements 
A major advantage in this study is the systematic collection of quantitative exposure data 
with a design to obtain information both on exposure intensity and variability (Heederik et 
al. 2000). 
This group based sampling strategy utilizes the fact that Berkson type of error causes little 
bias (Berkson 1950). The approximate exposure is used for all subjects within the group; 
and the true exposures, although unknown, may be assumed to vary randomly from this 
approximate , with mean equal to it (Nieuwenhuijsen 2003). 
The analytical measurement error is considered to be small, as well-known methods are 
used in this study. A systematic error can be introduced if values are consistently too high or 
too low due to calibration error in the sampling equipment. If this results in an over-
estimation of exposure, a decreased risk estimate will be the result, whereas an under-
estimation of exposure will give increased risk estimates. There is no reason to believe there 
were problems with measurement error in the field study as one laboratory trained person 
had the main responsibility at the plant. 
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Confounding  
Confounding is confusion, or mixing, of effects; the effect of the exposure is mixed together 
with the effect of another variable, leading to bias (Rothman 2002). If not adequately 
controlled for in the design or analyses, a confounder may bias the exposure-effect 
association either farther away or closer to the null than to the true effect. This can be 
accounted for either by adjustment or stratification. The most important confounders should 
then be included in the analysis. 
Age can be a confounder if it is associated with the exposure under study. That is, if the 
exposure of interest is time-related, e.g. cumulative exposure or duration of employment, 
age can be a confounder. The degree and direction of confounding cannot be anticipated 
when the exposures are not directly related to age, e.g. job group (Consonni et al. 1997). 
Lung function also decreases with age (Fletcher et al. 1977). In this study age was adjusted 
for, and is not considered to have introduced a bias. 
Smoking could be a possible confounder as smoking is known to yield a higher prevalence 
of respiratory symptoms and a larger annual decline in FEV1 (Kohansal et al. 2009). 
Smoking was adjusted for in the model using self-reported, baseline data for smoking, 
stratified in three smoking categories (current smoker, ex-smoker, non-smoker). Among 
those who participated twice, 86% answered identically in 2010 as in 2007 regarding 
smoking status. Approximately 6% reported to have stopped smoking during the follow-up 
period. No statistical significant difference in the percentage of the smoking categories in 
2007 compared to 2010 was found. 
Socioeconomic differences are known to cause differences in health (Eagan et al. 2004, 
Johannessen et al. 2010). The causal direction is not clear and suggests the question of 
whether low social position leads to poor health (social causation) or whether poor health 
leads to low social position (health selection) (Mæland 2009). The majority of the workers 
were skilled, had income through the work, and the living conditions were relatively equal 
and of good standard. Socioeconomic differences are considered to be of little importance in 
this cohort. 
Other risk factors such as genetic factors, particularly α1-antitrypsin (Larsson 1978); long-
standing asthma (Cassino et al. 2000); outdoor air pollution (Gauderman et al. 2007, Rojas-
Martinez et al. 2007); second-hand smoke exposure (Eisner et al. 2005, Skogstad et al. 
2006); and biomass smoke (Caballero et al. 2008) are not considered to cause confounding 
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in our study. Genetically the employees are hypothetically a homogeneous group being 
predominantly male Norwegians; α1-antitrypsin and long-standing asthma were observed, 
but in such low numbers that it does not have any effect on the results; outdoor air pollution 
is expected to be identical for those living in the same areas; biomass smoke is primarily 
outdoors in Norway and as such not a problem here, whereas second-hand smoke exposure 
could be. 
 
Discussion of the results  
Exposure assessment (Paper I) 
The exposure assessment strategy for this study was designed to be used in the 
epidemiological study on possible association between exposure and change in lung 
function.  
Quantitative exposure data was collected for 15 months of the three-year study period. This 
is important in epidemiological studies because the exposure often varies in time. All 
workers were eligible for the exposure study and workers who carried personal sampling 
equipment were selected at random to allow inference concerning exposure level for the 
entire population and use of proper statistical tools. The goal was to measure each worker 
for at least two days, however, because the study investigators could not be routinely be on 
site, the recommendation to sample each person twice was difficult to achieve. Only 23% of 
the workers had repeated measurements. 
New statistical approaches concerning handling of measurements below the limit of 
detection (LOD) have evolved over the last few years (Hewett et al. 2007). A classic 
approach of analysing datasets that include measurements below LOD is to insert LOD/2 or 
LOD/√2 for observations below LOD (Hornung et al. 1990). Summary statistics are then 
calculated using these inserted numbers. However, if the proportion of data with 
measurements below LOD is large this method is not optimal. Instead, we used maximum 
likelihood estimation (MLE) to compute summary statistics. To perform MLE computations 
the program uses the numerical values above the limit of detection, information on the 
proportion of data below the limit of detection, and a mathematical formula for an assumed 
distribution of the data. Exposure data in this study was shown to be lognormal distributed. 
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An analysis using the observed values (Eduard 2002) was performed and the results were 
found to be similar (results not shown). 
Even though it was not possible to refine the exposure assessment into e.g. cumulative 
exposure, the group-based strategy still provide valuable information making it possible to 
divide the workers into similarly exposed job groups. Many studies from similar industries 
are based upon self-reported information on exposure, job exposure matrix, or stationary 
sampling. 
In epidemiologic studies of the effect of workplace exposures on the frequency and 
distribution of diseases among groups of workers, it is common to use exposure metrics that 
do not indicate short-term peak exposure (e.g. cumulative exposure) (Ulvestad et al. 2001, 
Kauffmann et al. 1982). However, often the toxicological mechanisms explaining how 
exposures cause disease are unknown. In such situations, it has been discussed that short-
term peak exposures might cause different and more severe effects than the same exposure 
with lower intensity over a longer time period, because peaks may produce an elevated dose 
at target organ or overloading repair and protective mechanisms (Nieuwenhuijsen et al. 
1995, Oberdorster 1995). 
In this study, we found that for most agents the time weighted averages were generally low, 
however, when using PIMEX and direct reading instruments we found that the inhalation 
exposure profile of these workers consisted of successive exposure peaks resulting from 
many short term tasks during inspection rounds. 
Although self-reported information on what kind of work the person had performed on the 
day of personal sampling was collected, it was not possible from this information to know 
which tasks had more exposure or the exact exposure time. The rounds the workers perform 
include many tasks, and knowing which one to focus on will improve the information on 
exposure in a study. Other studies have shown that most of the exposure occurs during a 
short time (Meijster et al. 2008, Skaugset 2014). Subsequently, this information could be 
used to better understand the correlation between exposure and health effects. Although the 
PIMEX study turned out to have limited scientific value and hence was not published, the 
information gathered nevertheless was valuable for the company in a preventive 
perspective. 
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Lung function (Paper II and III) 
Smoking and occupational exposure to dust and fumes are the most important risk factors in 
developing obstructive pulmonary disease (Fletcher et al. 1977, Kohansal et al. 2009, 
Becklake 1985, Blanc et al. 2009, Omland et al. 2013). 
In this longitudinal study of workers at a Norwegian fertiliser plant, an overall statistically 
significant decline in FEV1 of 18 mL/yr during the three-year follow-up (Paper II) was 
found. Other studies from the occupational setting has found an adjusted decline of e.g. 8 
mL/yr (Kauffmann et al. 1982),8-10 mL/yr (Hnizdo et al. 2003), and 25 mL/yr (Ulvestad et 
al. 2001). Studying each job group, the workers in the nitric acid department had a 
statistically significant decline in FEV1 although this group was among the lowest exposed 
group in the study (Paper II). There was a statistically significant decline in DLCO of 0.068 
mmol/min/kPa/year (Paper III). On DLCO, the job group “Other” was the only group with a 
statistically significant decline. The statistical analyses showed no significant difference in 
lung function change between the job groups (Paper II and Paper III), and the differences in 
lung function change for the different job groups must therefore be interpreted with caution. 
The longitudinal design in which the subjects serve as their own controls at follow-up is 
considered as a major strength of this study. The number of participants was acceptable 
(Berry 1974); the follow-up time of three years is within acceptable limits (Bakke, PS et al. 
2011); the examinations were performed at the same time of the year, which reduced the 
effect of seasonal variation known to affect lung function (Senthilselvan et al. 2000); and 
the lung function examinations were performed by one person only using the same 
equipment, thus reducing the between-worker and within-worker variance. 
The linear mixed model corresponds well with known reference values regarding the 
expected decline due to age, gender and height (discussed later in the statistics paragraph). 
As for the spirometric values the mixed model estimates about the same values as that of the 
ECSC reference population regarding FEV1 and a little above regarding FVC. Quanjer et al 
uses a population of non-smokers without prior diseases known to affect lung function, but 
does not exclude on respiratory symptoms (Quanjer et al. 1993). In addition, this reference 
population is derived from several unrelated studies performed between 1960 and 1980 with 
different standards. Gulsvik et al has a population of asymptomatic people, but includes 
smokers and ex-smokers (Gulsvik 1979), whereas Langhammer et al only includes 
asymptomatic, non-smoking people (Langhammer et al. 2001). Similarly, the model fits 
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well with the reference values for gas diffusion (Gulsvik et al. 1992, Cotes et al. 1993). A 
lower measurement of FEV1 in an adult cannot be known whether to be due to not having 
achieved a high maximum during early adulthood, to having a shortened plateau phase, or 
an accelerated decline, or a combination of these three (Kerstjens et al. 1997). 
The exposure assessment is both a strength and a limitation in this particular study. Having 
a quantitative exposure assessment, modelling cumulative exposure with lung function 
change and refining it with short-term peak episodes might have been possible if the 
measured concentrations were higher. With many measurements below LOD, job groups 
were used as a proxy for exposure. The job groups in this study were selected to reflect 
differences in exposures.  
The observed decline in lung function in this study could also be a result of former 
hazardous exposures having initiated a “vicious circle” including inflammation in the 
airways (Lapperre et al. 2006, Yanbaeva et al. 2007). A previous study was performed on 
the same site as our study and provides some information on earlier exposure (Fandrem et 
al. 1993). The exposure estimates from the period 1966-87 in this particular plant are higher 
than the present measurements, showing means from the measurements of total dust from 
3.2 to 17.8 mg/m3 (Fandrem et al. 1993). Since then, the company has built two new 
factories and the oldest one from that time has closed. Improvements in production 
equipment occur periodically, and e.g. during the follow-up of this study the company 
installed a new, enclosed production line in the packing department. 
No statistically significant difference in lung function change over 3 years was found when 
comparing those with employment longer than 25 years to those with employment less than 
25 years. The decline in FEV1 (unadjusted) was not influenced by the number of years 
worked at the plant (figure 11).  
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Figure 11. Change in FEV1 by total years worked at the company 
Some workers had accidentally been exposed to high levels of ammonia, nitrous gases or 
chlorine. An attempt was made to study whether earlier peak exposures could be a cause of 
an increased risk of lung function decline, but the group had too few cases to analyse. 
A large population of ex- and current smokers was included, varying from 52% to 79% 
depending on the department. It cannot be excluded that the decline in lung function 
detected in this study could be caused by the effect of smoking, although smoking was 
adjusted for by inclusion in the model. Sustained pulmonary and systemic inflammation 
may persist 10-20 years after smoking cessation, thus giving an accelerated decline in FEV1 
in the ex-smokers compared to the non-smokers (Yanbaeva et al. 2007, Kohansal et al. 
2009). However, it is known that smoking cessation is beneficial to lung function (Fletcher 
et al. 1977, Anthonisen et al. 2002, Viegi et al. 2007, Warnier et al. 2013). At the start of 
the observation period the FEV1 % predicted was 89% for smokers and 94% for ex-smokers 
as compared to non-smokers with 99%. 
The average age of the men was 47.8 years. The rate of loss in FEV1 is previously reported 
to accelerate somewhat with age (Fletcher et al. 1977).The relatively high age in our 
population could contribute to the decrease shown in the present cohort (Ware et al. 1990, 
Ware et al. 1996). However, the more elderly workers did not decline faster than the 
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younger, indicating that older age was not an important contributing factor for the group 
under study. 
In this study many exposure measurements were below the limit of detection. The 
employees were categorised into job groups, but this classification does not take into 
account the length of the observation period of each worker and differences in exposure 
levels between agents within and between groups. Looking at the higher exposure for the 
unloading job compared to the rest of the shipping area, it is opportune to consider whether 
the groups are appropriate. However, the job-groups are considered representative as the 
workers rotate among all the tasks in the departments, and therefore are prone to a similarity 
and frequency of the materials and processes with which they work. The workers seldom 
swap between departments. There was no information on temporary short-term leave (<1 
month) between the first and second lung function testing, which may have led to an 
overestimation of exposures. Because a substantial number of the measurements of all the 
agents were below the analytical limit of detection, no quantitative estimates of exposure 
was used to study the association between exposure and lung function decrease. This factor 
may have limited the possibility of obtaining optimal grouping of workers in this study. 
Exposure within job groups can show multi-fold variance, which may lead to 
misclassification and incorrect conclusions regarding the health - or no health - effects. 
All exposure measurements are made outside personal protective equipment (PPE) and the 
company provides them with PPE as needed for the various exposures. Depending on the 
work, like whether the exposure is dust or gas, different kind of respirators are used. 
According to information from many of the workers, the use of PPE has risen the last 
decades. Most of the time, the workers will know where and when the exposures will occur, 
and use PPE when mandatory or from their own judgement. In the nitric acid department all 
the workers have to carry a direct reading device when in the production area. This device 
will give an alarm whenever the gas concentration is above the Norwegian OEL of 0.6 ppm, 
and the workers are then to leave the area or use the required PPE. The cranes and dumpers 
have closed cabins and some also have over-pressure in the cabin. As the exposure estimates 
were not refined, this will not have lead to any error in our study. 
The compound fertiliser departments had the highest median levels of inhalable and thoracic 
concentrations (Paper I). The thoracic fraction is considered the most relevant for 
obstructive pulmonary disease (Vincent 2005), but the inhalable fraction gives valuable 
information on the particle size distribution. In the compound fertiliser departments the 
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mean extrathoracic fraction was 76% indicating that the majority of the aerosol will not 
reach the tracheobronchial region (European Committee for Standardization (CEN) 1993). 
Possible respiratory effects from aerosols may predominantly be related to the water-
insoluble aerosol-fraction, and water-solubility was characterised. It was not possible to 
calculate the partitioning of all the elements in the water-soluble fraction, but if Ca is 
representative of the water-soluble fraction, approximately one-half of the thoracic mass 
fraction is water-soluble. This information could not be used in a further refinement of 
exposure associated lung function decline. 
Short-term peak exposure episodes were observed for gases using direct reading instrument, 
and for dust and gases in the sub study using PIMEX. The association of these short-term 
peak episodes to lung function changes during follow-up could not be studied as not enough 
information on the quantity pro person of these episodes were available. Some other studies 
from the fertiliser industry found reduced lung function and a higher prevalence of reported 
respiratory symptoms related to ammonia exposure (Ballal et al. 1998, Rahman et al. 2007). 
Studies from other settings have shown NO2 to produce airway obstruction (Bakke, B et al. 
2001, Brooks et al. 1985). 
The question of the respiratory risk of short-term peak episodes to aerosols and gases, and 
long term work at relatively low levels of exposure in this industry thus remains an open 
one. 
Respiratory symptoms questionnaire 
Four respiratory symptoms that have been associated with various exposures in occupational 
settings in Norway (Fell et al. 2003, Ulvestad et al. 2000, Johnsen et al. 2008); cough, 
cough with phlegm, cough with phlegm > 3 months/year, and wheezing were included in 
the analyses. One of the studies from Norway encompasses some of the same workers as in 
this study (Fell et al. 2003). The overall prevalence of airway symptoms was lower than in 
other occupational studies from Norway, and of the four selected symptoms only cough 
showed a statistical significant change from 2007 to 2010. These symptoms have also been 
reported in a population study from Norway (Eagan et al. 2002). The wording and set-up of 
the questionnaires differ slightly, and also the prevalence of employees/people reporting 
symptoms.  
Discussion 
 64 
The prevalence of airway symptoms in this study appears low compared to similar 
industries (Zuskin et al. 2007) or compared to the other occupational settings studied in 
Norway (Randem et al. 2004, Fell et al. 2003). This finding was the case at baseline and at 
follow-up, and no associations were found between the reported symptoms and the change 
in lung function indices. Kanner et al have shown a tendency of respiratory symptoms to be 
associated with greater declines in FEV1 (Kanner et al. 1999). Fell et al found no difference 
in the prevalence of reported symptoms between controls and exposed workers in the 
cement producing industry (Fell et al. 2003). Regarding wheezing, the prevalence in this 
study was on the same level as the tunnel workers reported in Ulvestad et al’s study 
(Ulvestad et al. 2000), while the prevalence of morning cough and cough during the day 
were lower than the 30% and 17%, respectively, Ulvestad et al found. Laier Johnsen et al 
found a prevalence of 29% for cough and 24.8% for phlegm when coughing, among line 
operators in the Norwegian smelting industry (Johnsen et al. 2008). Reported prevalence of 
selected respiratory symptoms from some Norwegian studies is shown in table 10. 
Table 10. Percentage of selected self reported airway symptoms in various studies from 
Norway. 
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Wheezing 26.2 46 26 NA 22.0 
Morning cough 8.0 32 30 29 23.7 
Daily cough with phlegm 10.6 34 NA NA 11.5 
Cough with phlegm > 3 months/yr 6.5 34 NA 24.8 25.0 
NA not available 
 
Holland et al found that respondents might show a higher prevalence of symptoms when 
questions were asked in the winter than in the summer (Holland et al. 1969). The weather 
was colder during the follow-up in 2010 than in 2007 and this might contribute to the higher 
prevalence of cough in 2010 (Hyrkas et al. 2014). 
In a population study, Jakeways et al found that the odds of respiratory symptoms increased 
with declining levels of all FEV1 measures, particularly for wheeze and general breathing 
difficulty (Jakeways et al. 2003). Other studies have shown that reported respiratory 
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symptoms have a low predictive value on the measured results of lung function values 
(Stahl 2000). Thus, airway symptoms reported among workers must be interpreted with 
caution. 
 
Rhinometry 
The results were analysed and a statistical borderline correlation was found between nasal 
volume (VOL2) and FEV1 percent predicted using the ECSC reference equations (Quanjer 
et al. 1993) but not with the Gulsvik reference equations (Gulsvik 1979, Hovland 2008). 
There may be many reasons for a smaller volume in the nose, thus the specificity is low 
when used in isolation as here.  
Rhinometry has previously been used in occupational settings (Ulvestad et al. 2001, Heldal 
et al. 2003, Schlunssen et al. 2002), and an interaction between the upper and lower airways 
function has been demonstrated among patients with COPD without using decongestant 
(Hurst et al. 2006). Hellgren et al also studied nasal patency among exposed workers 
without using decongestant (Hellgren et al. 2001) and found no difference between exposed 
and control groups in the paper industry. Ulvestad et al and Heldal et al studied construction 
workers and waste handlers, respectively, and found a difference between exposed groups 
against references (Ulvestad et al. 2001, Heldal et al. 2003) studying the change in mucosal 
swelling from the decongestive effect. 
Using a decongestant could influence the lung function testing. Introducing a bias by using 
medication was decided against, as lung function was the major outcome of interest in this 
study. Thus, rhinometry was not repeated in 2010. 
 
 Analysing longitudinal data with a mixed model 
A mixed model approach gives several advantages to a more traditional approach that use 
only complete data with change in lung function as outcome variable and adjust for baseline 
covariates. The traditional approach avoids the problem with the dependency of repeated 
measurements as it considers one observation (change in lung function) for each worker. 
However, this is not without problems; removing individuals with non-complete 
observations gives potentially more biased estimates as it is less robust to the missing data 
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mechanism. By using mixed model all available observations can be exploited whereas 
removing individuals with non-complete observations results in less power (Fitzmaurice et 
al. 2011). 
It is instructive to see how the estimations from the longitudinal mixed model match the 
reference equations of ECSC (Quanjer et al. 1993), Gulsvik (Gulsvik 1979) and 
Langhammer (Langhammer et al. 2001) for the dynamic lung functions, and ECSC (Cotes 
et al. 1993) and Gulsvik (Gulsvik et al. 1992) for the diffusing capacity function. As the 
workers in the study population are predominately males only the reference equations for 
males are considered, and the mixed model predicted values are for male non-smokers 
without respiratory symptoms. The linear longitudinal mixed model almost overlaps with 
the ECSC reference values for FEV1 as seen in Figure 12, except for the lower age group, as 
the ECSC assumes constant lung function values for the 18 – 25 age group. The Gulsvik and 
Langhammer reference equations are clearly above the mixed model predictions, but follow 
approximately the same declining age trend. 
 
 
Figure 12. Comparison of reference equations, the mixed model predictions, 
and the average for all male FEV1 observations  
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The same tendency is shown for the FVC predicted values. Here, the mixed model 
predictions are slightly above the ECSC values (figure 13). 
 
 
Figure 13. Comparison of reference equations, mixed model predictions, 
and the average for all male FVC observations  
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Furthermore, for the DLCO values, the mixed model predictions are closest to ECSC; the 
mixed model predictions cross from being below the ECSC predictions for the ages below 
45, to be slightly above after 45 years of age. The expected annual declines were 
approximately the same as that of Gulsvik’s cross-sectional reference population, with 
-0.056 mmol/min/kPa compared to Gulsvik’s -0.057 mmol/min/kPa for men. The ECSC 
equations yield -0.066 /min/kPa for men (figure 14). 
 
Figure 14. Comparison of reference equations, mixed model predictions, 
and the average for all male FEV1 observations  
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Conclusions & recommendations 
Conclusions 
In this study of employees at a mineral fertiliser plant a larger than expected decline in lung 
function indices, both dynamic lung function and lung diffusing capacity, over the three-
year follow-up period was found. 
The employees were exposed to aerosols and gases, but the overall air concentrations were 
well below what is considered to cause health risks. The results indicate, though, that the 
workers may have experienced short-term peak episodes for both aerosols and gases when 
performing tasks such as e.g. quality control sampling and cleaning. 
The prevalence of respiratory symptoms was low compared to other studies from Norway, 
and only the prevalence of morning cough showed a statistically significant change during 
follow-up. No association between reported respiratory symptom and the decline in lung 
function was found among those reporting respiratory symptoms compared to those not 
reporting respiratory symptoms. 
A borderline correlation between rhinometry results and that of dynamic lung function at 
baseline using the ECSC reference equation was found, however there was no statistically 
significant correlation using the Gulsvik reference equation. 
With the measured exposure levels, no plausible exposure related explanation was found for 
the overall lung function decline. 
 
Recommendations 
The question from Yara when initiating this study was “Is there an increased risk of the 
employees getting COPD by working here?”  
The impression from this particular plant is that the awareness on exposure and possible 
lung function effects has been high, particularly in the last decade. Furthermore, the 
reported use of personal protective equipment appears to be adequate. The exposures seem 
to have declined over the last 20 years and the exposure assessment study provides a good 
characterisation of the present exposure of aerosols and gases. The focus onward should be 
on short-term peak exposures. 
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Ethical considerations 
 
The company and employees were concerned about whether work-related exposure could be 
a cause of obstructive pulmonary disease, and their concern led to this study. The 
occupational health service found, in a cross-sectional study, that the percentage of 
employees with obstructive pulmonary disease was higher in the fertiliser production areas 
compared to an internal reference group. 
In occupational settings, employees may feel an obligation to participate and it is essential 
to ensure that the participation is voluntary. Written and oral information was given to the 
employees at the plant about the study. All the participants signed consent forms at both 
times of the lung function testing. The employees were informed that they could withdraw 
from the study at any time without stating any reason. 
All the employees were invited to participate in the study. The study was approved by the 
Regional Ethics Committee and by the Norwegian Social Science Data Services (NSD). 
All the participants received information on the result of their own lung function test. The 
physician instructing the subjects would notify the occupational health service if further 
follow-up was required. 
Initially, the right to publish freely the results of the studies was ensured. Yara Norge AS 
and the Confederation of Norwegian Enterprises (NHO) are gratefully acknowledged for 
their financial support. 
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Appendix I  Information letter 2007 
 
 
UNDERSØKELSE AV LUNGEFUNKSJON 
Forespørsel til ansatte ved YARA Porsgrunn. 
 
Som dere kjenner til er det blitt stilt spørsmål om det er en sammenheng mellom 
eksponering i arbeidsmiljøet deres og nedsatt lungefunksjon. Helseundersøkelser som er 
foretatt av Herøya Bedriftshelsetjeneste kan tyde på dette.  
Yara Porsgrunn ønsker å få avklart om dette medfører riktighet, og har inngått en avtale 
med Statens arbeidsmiljøinstitutt om en større undersøkelse av dette. En del av denne 
undersøkelsen er å følge dere som er ansatt ved bedriften, med prøver i forhold til 
lungefunksjon. 
Vi ønsker i denne forbindelsen at du deltar i undersøkelse med spørreskjema, spirometri, 
TLCO (blåseundersøkelser), og akustisk rhinometri 2 ganger i perioden 2006-2010. 
Vi har fått tilgang til navnet ditt gjennom personalavdelingen i bedriften. For at vi skal 
kunne stole på resultatene vi finner, er det viktig at så mange som mulig deltar i 
undersøkelsen. 
 
Det er frivillig å delta i undersøkelsen. 
 
Pusteprøve/Spirometri 
Er en undersøkelse hvor du skal blåse i et instrument. Det forteller noe om lungefunksjonen 
din. (samme undersøkelse som bedriftshelsetjenesten gjør) 
Blåseundersøkelse - TLCO 
Er en undersøkelse hvor en puster inn en bestemt mengde blandingsgass, holder pusten i 10 
sek, og deretter blåser det ut. Det viser gassutveksling mellom lunge og blodet. 
Appendices 
 86 
 
”Neseromsundersøkelse” - Akustisk rhinometri 
Er en undersøkelse hvor det blir holdt et lite instrument,”ekkolodd”, foran neseåpningen, 
som registrerer romforholdene i nesen.  
 
Spørreskjema 
I forbindelse med vurdering av forekomst av lungesykdommer er det viktig å få informasjon 
fra deg om 
x Symptomer du evt har fra luftveiene. 
x Sykdomshistorie, spesielt med henblikk på hjerte- og lungesykdommer 
x Eksponering på arbeidsplass (både nåværende og evt tidligere), og evt fritid. 
x Røykevaner  
Vi ser at det kan være vanskelig å huske alt, men ber deg svare så godt du kan. 
 
Dersom du ønsker å delta i undersøkelsen ber vi deg om å fylle ut og undertegne 
vedlagte samtykkeerklæring, og returnere dette sammen med spørreskjemaet til 
prosjektlege Kristin Hovland samtidig som du kommer til undersøkelse. 
 
Vi vil selvsagt melde fra om eventuelle funn ved undersøkelsen til den enkelte. Ved behov 
blir du henvist til Bedriftshelsetjenesten for videre oppfølging.  
 
Den informasjonen vi innhenter gjennom undersøkelsene og skjemaet, vil vi samle og 
analysere. Resultater blir registrert, uten navn, på data for videre bearbeiding. Hvis du ikke 
motsetter deg det, vil Herøya Bedriftshelsetjeneste få resultatene av undersøkelsene, for 
oppfølging på et senere tidspunkt. Alle prosjektmedarbeiderne har taushetsplikt. 
 
Vi regner med å avslutte dette prosjektet i 2010. Med tanke på eventuelt å kunne gjøre 
oppfølging av studien på et senere tidspunkt, ber vi om tillatelse til å lagre dataene for 
ettertiden (5-10 år), i avidentifisert form. Dataene vil bli avidentifisert like etter at prosjektet 
er avsluttet i 2010. Det betyr at navn og fødselsnummer ikke lagres sammen med 
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helseopplysningene, men at det vil være mulig ved hjelp av en kodenøkkel å finne tilbake til 
navn og fødselsnummer dersom innhenting av nye opplysninger skulle bli aktuelt. 
 
Du kan når som helst trekke deg fra prosjektet uten nærmere begrunnelse og uten at det skal 
få negative konsekvenser. 
 
Prosjektet er tilrådet av Regional etisk komité for medisinsk forskningsetikk og 
Personvernombudet for forskning, Norsk samfunnsvitenskapelig datatjeneste. Det er støttet 
økonomisk av Yara Porsgrunn. 
 
Hvis du har noen spørsmål er det bare å ta kontakt 
Tlf 23 19 51 34 
e-post: kristin.hovland@stami.no 
 
Oslo 06 
 
Vennlig hilsen 
Statens arbeidsmiljøinstitutt 
 
 
Knut Skyberg    Kristin Hovland 
Overlege, dr.med   Prosjektlege 
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Appendix II Information letter 2010 
 
 
UNDERSØKELSE AV LUNGEFUNKSJON 
 
Siden 2006 har Yara Porsgrunn i samarbeid med STAMI (Statens arbeidsmiljøinstitutt) og 
Bedriftshelsetjenesten jobbet med "KOLS-prosjektet" som har til hensikt å undersøke en 
mulig sammenheng mellom nedsatt lungefunksjon og støv og gasser i vårt arbeidsmiljø. 
 
Nå er prosjektet i en sluttfase. Som det ble gitt informasjon om ved forrige 
lungefunksjonsprøve i 2007, skal den gjentas i 2010 for å se på endringer i denne perioden. 
Tiden er nå kommet for å gjennomføre denne målingen, med start i januar 2010. 
 
Prosjektet er forankret i Arbeidsmiljøutvalget (AMU). Nye lungefunksjonsprøver 
(blåseprøver) sammen med et enkelt spørreskjema, vil gi viktig informasjon for å vurdere 
mulige sammenhenger. 
 
Deltagelse er frivillig, men det er svært viktig for selve undersøkelsen at alle som deltok 
forrige runde også deltar nå. Det var i alt ca 350 deltakere i 2007. 
 
Selve gjennomføringen av undersøkelsen skjer i regi av STAMI og vil foregå ute i 
avdelingene. 
 
Pusteprøve/Spirometri 
Er en undersøkelse hvor du skal blåse i et instrument. Det forteller noe om lungefunksjonen 
din. (samme undersøkelse som bedriftshelsetjenesten gjør) 
 
Blåseundersøkelse - TLCO 
Er en undersøkelse hvor en puster inn en bestemt mengde blandingsgass, holder pusten i 10 
sek, og deretter blåser det ut. Det viser gassutveksling mellom lunge og blodet. 
 
Spørreskjema 
I forbindelse med vurdering av forekomst av lungesykdommer er det viktig å få informasjon 
fra deg om 
x Symptomer du eventuelt har fra luftveiene. 
x Sykdomshistorie, spesielt med henblikk på hjerte- og lungesykdommer 
x Eksponering på arbeidsplass (både nåværende og tidligere), og eventuelt fritid. 
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x Røykevaner  
 
Vi ser at det kan være vanskelig å huske alt, men ber deg svare så godt du kan. 
Dersom du ønsker å delta i undersøkelsen ber vi deg om å fylle ut og undertegne 
vedlagte samtykkeerklæring og returnere dette til prosjektlege Kristin Hovland 
samtidig som du kommer til undersøkelse. Spørreskjemaet vil bli delt ut før 
undersøkelsene starter. 
 
 
Vi vil gi tilbakemelding på undersøkelsen til den enkelte. Ved behov blir du henvist til 
Bedriftshelsetjenesten for videre oppfølging. 
 
Den informasjonen vi innhenter gjennom undersøkelsene og skjemaet, vil vi samle og 
analysere. Resultatene blir registrert, i avidentifisert form på data for videre bearbeiding. 
Alle prosjektmedarbeiderne har taushetsplikt. 
 
Alle opplysninger vil bli behandlet og oppbevart i avidentifisert form etter prosjektets slutt. 
Det betyr at navn og fødselsnummer ikke lagres sammen med helseopplysningene, men at 
det vil være mulig ved hjelp av en kodenøkkel å finne tilbake til navn og fødselsnummer 
dersom innhenting av nye opplysninger skulle bli aktuelt. Vi regner med å avslutte dette 
prosjektet i 2010. Med tanke på eventuelt å kunne gjøre oppfølging av studien på et senere 
tidspunkt, ber vi om tillatelse til å lagre dataene i avidentifisert form i ca7 år. Dersom det 
ikke blir aktuelt med en oppfølgingsstudie i løpet av denne tidsperioden vil datamaterialet 
anonymiseres senest 31.12.2017.  
 
Du kan når som helst trekke deg fra prosjektet uten nærmere begrunnelse og uten at det vil 
få negative konsekvenser i forhold til arbeidsgiver eller bedriftshelsetjeneste. 
Prosjektet er tilrådet av Regional komité for medisinsk forskningsetikk og 
Personvernombudet for forskning, Norsk samfunnsvitenskapelig datatjeneste. Det er støttet 
økonomisk av Yara Porsgrunn. 
 
 
Hvis du har noen spørsmål er det bare å ta kontakt 
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på telefon 23 19 51 00 eller 
e-post: kristin.hovland@stami.no 
 
Oslo januar 2010 
 
Vennlig hilsen 
Statens arbeidsmiljøinstitutt 
 
 
Knut Skyberg    Kristin Hovland 
Overlege, dr.med   Prosjektlege 
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Appendix III Consent form, 2007 and 2010 
 
 
SAMTYKKESKJEMA 
 
Helseundersøkelse for ansatte ved Yara Porsgrunn 
 
Jeg har mottatt informasjon om prosjektet og er klar over at deltagelse i prosjektet er 
frivillig og at jeg når som helst kan trekke meg fra prosjektet dersom jeg ønsker det, uten å 
oppgi grunn. 
 
Jeg samtykker med dette i at følgende opplysninger om meg benyttes i 
forskningsprosjektet ”Undersøkelse av lungefunksjon hos ansatte ved Yara”, og at disse 
opplysningene lagres for ettertiden, i avidentifisert form 
 
x Opplysninger fra vedlagte spørreskjema 
x Resultater fra undersøkelser som blir utført 
 
 
Jeg samtykker i at helseopplysningene blir overført til Herøya Bedriftshelsetjeneste.  
 
 
Navn (blokkbokstaver)    Fødselsnummer (11 siffer) 
 
 
Underskrift      Dato  
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Appendix IV Respiratory symptoms questionnaire, 2007 and 
2010 
 
 
SYKDOMMER du har eller har hatt 
 
Har du blitt behandlet av lege eller på sykehus for 
lungebetennelse eller bronkitt? Ja Nei 
 Som barn, 0-14 år gammel   
 Som ungdom, 15-20 år gammel   
 Som voksen   
 
Har du blitt behandlet av lege eller på sykehus for 
noen av de følgende sykdommene?    Kryss av 
 Øyeallergi, neseallergi eller høysnue     
 Eksem, inkludert barneeksem     
 Tuberkulose     
 Pleuritt     
 Sarkoidose                                                                         
 Støvlungesykdom, f.eks. silikose, asbestose     
 Lungefibrose                                                                       
 Emfysem el.KOLS (kronisk obstruktiv lungesykdom)     
 Koronar hjertesykdom (hjerteinfarkt eller angina)     
 Andre hjertesykdommer, i så fall oppgi hvilke:     
 
……………………………………………………………………………... 
ALLERGI 
                                                                                                                                                                                                        Ja Nei 
Har du noen gang hatt allergi mot f.eks. gress, dyr?   
Hvis ja, oppgi hvilken type allergi: 
……………………………………………………………………………… 
Hvis ja, hvilke symptomer har/hadde du?      Kryss av 
 Symptomer fra øynene, renning      
 Symptomer fra nesen, nysing, rennende eller tett nese     
 Astma     
 Hudsymptomer, eksem, eller kløende utslett     
  Ja Nei 
Har en lege bekreftet din allergidiagnose?   
 
Har noen i din familie noen gang hatt allergi? Ja Nei 
 Mor, far eller søsken   
 Barn   
 Ektefelle   
 
ASTMA 
  Ja Nei 
Har du noen gang hatt astma?   
Hvis “ja”,      Kryss av 
 -Ja, som barn eller ungdom      
 -Ja, som voksen     
 -Ja, fremdeles / nå     
  Ja Nei 
Har du hatt astmaanfall i løpet av de siste 12 månedene?   
Tar du medisiner mot astma (inkl. inhalatorer, aerosoler 
 og tabletter)?   
Startet din astma (første gang) i løpet av de siste ti årene?   
Har en lege bekreftet din astmadiagnose?   
 
Har noen i din familie noen gang hatt astma:                       Kryss av 
 Mor, far eller søsken?   
 Barn?   
 Ektefelle?   
 
 
SYMPTOMER FRA LUFTVEIENE, nåværende og tidligere  
  Ja Nei 
Har du hatt hvesing eller piping i brystet på noe 
tidspunkt i løpet av de siste 12 månedene?   
 
Har du blitt vekket av en følelse av å være tett i  
brystet om morgenen i løpet av de siste 12 månedene?    
 
Har du på noe tidspunkt i løpet av de siste 12 månedene  
hatt anfall av tungpustenhet i løpet av dagen uten at du  
hadde anstrengt deg?    
 
Har du på noe tidspunkt i løpet av de siste 12 månedene 
hatt anfall av tungpustenhet som kom etter at du hadde  
gjennomført fysisk trening?   
 
Har du på noe tidspunkt i løpet av de siste 12 månedene  
blitt vekket om natten av et anfall av tungpustenhet?   
 
Har du på noe tidspunkt i løpet av de siste 12 månedene  
blitt vekket om natten av et hosteanfall?   
 
Hoster du som regel når du våkner om morgenen?   
 
Hoster du som regel opp slim fra lungene (oppspytt) når 
du våkner om morgenen?   
 
Har du hostet opp slim fra lungene (oppspytt) de fleste  
morgenene minst tre måneder hvert år?   
 
Hvilket av de følgende utsagn beskriver din pust best? 
      a) Jeg har aldri / svært sjelden problemer med pusten   
      b) Jeg får regelmessig problemer med pusten, men  
          det blir alltid fullstendig bra igjen etterpå   
      c) Min pust er aldri helt bra   
 
Når du er i støvete deler av huset eller sammen med dyr 
 (f.eks. hunder, katter eller hester) eller i nærheten av fjær 
 (f.eks. puter, dyner, edderdun), opplever du noen gang: 
       a) Å få en følelse av å være tett i brystet?   
       b) Å bli tungpusten?   
 
RØYKING 
  Ja  Nei  
Røyker du nå (siste måned)?   
 
Hvis du ikke røyker daglig nå, har du noen gang røykt 
minst en sigarett pr. dag i et helt år?    
   
Hvis du har røykt tidligere, men ikke røyker nå:               Kryss av 
Sluttet du å røyke for mindre enn et år siden?     
Sluttet du å røyke for et år siden eller mer?     
 
Hvis du røyker eller har røykt tidligere:             år 
Hvor gammel var du da du begynte å røyke?        Alder:  
 
Hvor mange år har du røykt til sammen?          Antall år:  
 
Hvor mye røyker/røykte du i gj. snitt? Antall 
 (antall sigaretter per dag)  
Navn  
Dato  
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Appendix V  Work exposure questionnaire, 2010 
 
Navn: 
Fabrikk og skift: 
 
1. Har du hatt de samme arbeidsoppgaver/jobbet ved samme fabrikk siste 3 år Ja Nei 
(siden forrige lungeundersøkelse)? 
 
Hvis nei, kan du skrive hvor du har jobbet? (inkludert arbeid utenfor  
Yara/permisjon/langvarig sykdom eller lignende) 
 
Tidsrom  Arbeidssted 
 
 
 
 
2. Vennligst skriv ned alle jobbene du har hatt etter vanlig skolegang. (med varighet mer 
enn 1 år) 
(For arbeid ved Hydro/Yara vennligst skriv hvilke fabrikker, hvis du har jobbet ved 
flere over lengre perioder) 
 
Tidsrom  Bedrift   Stilling/yrke 
 
 
 
 
3. Har du noen gang arbeidet med/vært eksponert for følgende i 1 år eller mer? 
      
a) Asbest        Ja   Vet ikke  Nei 
b) Kvarts        Ja   Vet ikke  Nei 
c) Jordbruksproduksjon (bondeyrket)    Ja   Vet ikke  Nei 
d) Sveising og platearbeid     Ja   Vet ikke  Nei 
e) Isocyanater       Ja   Vet ikke  Nei 
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4. Har du noen gang vært til lege/sykehus pga akutt gass forgiftning? 
a) Nitrose       Ja Nei 
b) Ammoniakk       Ja Nei 
c) Klor        Ja Nei 
d) Annet        Ja Nei 
I tilfelle når? 
 
 
5. Har du regelmessig fritidsaktivitet(er) som gir støv- eller 
gassforurensing av innåndingsluften?     Ja Nei 
 
Hvis ja, hva slags aktivitet? 
 
 
6. Hvor mange dager per uke/skiftperiode jobber du bare i kontrollrommet?
 ….dager/uke/periode 
7. Roterer du på de forskjellige utejobbene?    Ja Nei 
 Hvis nei, hvilke jobber går du på? 
 
8. Bruker du støvmaske/åndedrettsvern når det er pålagt?        Alltid  Ofte  Av og til  Aldri 
 
9. Har du endret røykevaner siste 3 år?     Ja Nei 
Hvis ja, hvordan? (f.eks økt/redusert antall sigaretter, sluttet, begynt igjen) 
 
 
Takk for at du tok deg tid til å svare på spørsmålene! 
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Appendix VI Short overview of prevalence and incidence of 
COPD and the development of standardisation 
Pulmonary obstruction 
A short overview of the prevalence and incidence of COPD and the development of 
standardisation is included because the concern about a higher prevalence of COPD among 
the employees at the fertiliser production plant initiated this study. 
Prevalence/incidence 
COPD is expected by the WHO to be the third most common cause of mortality by 2020 
(http://www.who.int/respiratory/copd/burden/en/index.html), yet most national data show 
that less than 6% of the adult population has been told about having COPD (Vestbo et al. 
2012). In Norway, two studies show a prevalence of COPD of 4.1% and 4.5% (Bakke, PS et 
al. 1991, Gulsvik, A. 1979). This percentage most likely reflects under-recognition and 
under-diagnosis of COPD. In another study from Norway, Johannessen et al estimated that 
only about one-half of those with COPD are diagnosed (Johannessen et al. 2005). The same 
trend is found in Sweden (Lindberg et al. 2006). The cumulative incidence of the GOLD-
defined chronic obstructive pulmonary disease in a general adult population in Western 
Norway was 6.1% (Johannessen et al. 2005). Lindberg et al found a ten-year cumulative 
incidence in Northern Sweden of 8.2% (using BTS criteria) and 13.5% (using GOLD 
criteria) (Lindberg et al. 2005). 
Pulmonary obstruction is preferably diagnosed with spirometry test. Earlier this diagnostic 
procedure was a suggestion in the GOLD criteria, but it is now a requirement in the latest 
GOLD update (Vestbo et al. 2012). Globally this criterion is not practicable, and the 
diagnosis must be made on symptoms only. In epidemiological studies respiratory 
symptoms have been used as criteria for obstructive disease (Heederik et al. 1990, 
Lundback et al. 1994, Gulsvik, A. 1979) Spirometry is a crucial test, however, and has been 
applied in epidemiological studies (Johnsen et al. 2008, Ulvestad et al. 2000) and in the 
clinic for years. Because the definition on obstructive abnormality has varied over the 
continents and through the years (Vestbo et al. 2012, Quanjer et al. 1993, 1997), it is 
difficult to assess the burden of obstructive disease in the population (Lindberg et al. 2005).  
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Standardisation 
Regarding questionnaires on respiratory symptoms the British Medical Research Council 
published the first standardised questionnaire in 1960 (British Medical Research Committee 
1960). This questionnaire was developed in a setting where smoking and use of coal/mining 
(the London Smog) caused chronic obstructive disease. Thus, the questionnaire had only a 
few questions on wheezing (British Medical Research Committee 1960, Toren et al. 1993). 
The following questionnaires included more questions on asthma such as American 
Thoracic Society’s questionnaire of 1978 (Alavanja et al.) and the International Union 
Against Tuberculosis and Lung Diseases (IUATLD) in the 1980s (Burney, P et al. 1987). In 
Norway, Kongerud et al validated a translated, modified MRC questionnaire (Kongerud et 
al. 1989). The ECRHS used several pre-existing questionnaires to develop the questionnaire 
for their survey (Burney, PG et al. 1994). 
With this discussion on terminology and the development of questionnaires, there emerged a 
standardisation for pulmonary function testing. ATS published a document on 
“Standardization of Spirometry” in 1979 (1979), including subsequent updates. The 
ECSC/ERS published their statements from 1983 onward (1983). In 2005, ATS and ERS 
published a joint statement, which is currently in use (Miller et al. 2005). 
Criteria 
In the late 1990s, a committed group of scientists wanted to bring more attention to the 
prevention and management of COPD and, on behalf of the US Heart, Lung, and Blood 
Institute (the NHLBI) and the WHO, founded the Global Initiative for Chronic Obstructive 
Lung Disease (GOLD). The first consensus report was available in 2001 (Pauwels et al. 
2001), with the last update in 2011 (Vestbo et al. 2012). The GOLD document of 2011 
states that: “Chronic Obstructive Pulmonary Disease (COPD), a common preventable and 
treatable disease, is characterized by persistent airflow limitation that is usually 
progressive and associated with an enhanced chronic inflammatory response in the airways 
and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to 
the overall severity in individual patients.” The primary mechanisms underlying airflow 
limitations in COPD are: small airway disease, airway inflammation, airway fibrosis, 
luminal plugs, and increased airway resistance on one hand, and parenchymal destruction, 
loss of alveolar attachments, and decrease of elastic recoil on the other hand. 
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The document states that any person with dyspnoea, chronic cough or sputum production, 
and/or a history of exposure to risk factors for the disease and age above 40 should be 
considered for COPD. The spirometry test, including post-bronchodilator spirometry, is 
required for the diagnosis according to GOLD. Airflow limitation without concordant 
symptoms is possible. Cellular and molecular indices are not yet mandatory for the 
diagnosis. The recommendation states that screening for α1-antitrypsin (AAT) deficiency 
should be performed in COPD patients from high prevalence areas and young (<45 years) 
COPD patients. 
GOLD is effective with a clinical diagnosis and maintains the post-bronchodilator ratio of 
FEV1/FVC < 0.7 with four grades of the degree (mild, moderate, severe, and very severe) of 
airflow limitation as before (split at 80%, 50% and 30% of predicted value). In addition, the 
GOLD criteria recommend the assessment of symptoms, lung function, risk of 
exacerbations and comorbidities.  
The current ATS/ERS guideline requires post-bronchodilator spirometry test for the 
diagnosis (Celli et al. 2004). The ATS/ERS have spirometric classification equal with that 
of GOLD, except the stadium “At risk” with FEV1/FVC < 0.7 and FEV1 % predicted ≥80. 
At risk is defined as; ”patients who smoke or have exposure to pollutants, have cough, 
sputum or dyspnoea” (Celli et al. 2004). 
There is an ongoing discussion of whether the FEV1/FVC ratio <0.7 or Lower Limit of 
Normal (LLN) should be used in diagnosing airflow obstruction. Lower Limit of Normal 
refers to the statistically lower fifth percent of a reference population and is calculated by 
subtracting 1.64 times the standard deviation (SD) from the mean. It has been shown that a 
fixed ratio under-estimates the diagnosis among the young (Cerveri et al. 2008) and over-
estimates the diagnosis among the elderly (Hardie et al. 2002). For epidemiological studies 
on COPD, ERS published a task force report in 2011 (Bakke, PS et al. 2011) that 
recommends using the LLN (post-bronchodilatory) to define COPD. Swanney et al 
(Swanney et al. 2008) claim that using the LLN rather than the FEV1/FVC ratio reduces the 
misclassification of airway obstruction. In the article by Swanney et al, a figure showing the 
reference values for the LLN range from 57 studies is shown, and these data indicate the 
importance of selecting the right reference population. There are few, if not only one, 
reference equation based on post-bronchodilatory values (Johannessen et al. 2006). 
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Appendix VII Lung diffusing capacity 
Although spirometry test is the “gold standard” for examining lung function, diffusing 
capacity is widely used as a supplement in clinical medicine. It has been used in population 
based and in occupational epidemiological studies (Nogueira et al. 2011, Welle et al. 1999). 
The single-breath determination of carbon-monoxide uptake in the lung (DLCO) was first 
described by Marie Krogh in 1915 (Krogh). The term “transfer factor for carbon monoxide” 
(TLCO), expressed as mmol/min/kPa (SI unit), is primarily used by the European 
community, whereas North Americans use “lung diffusing capacity for carbon monoxide” 
(DLCO), expressed as mL/min/mmHg (the conversion factor is “TLCO”(SI unit) = ” 
DLCO”/2.896). The joint ATS/ERS standardisation as of 2005 (MacIntyre et al. 2005) uses 
DLCO. It is a product of the CO uptake from the lung (Kco – carbon monoxide transfer 
coefficient) and the alveolar volume, VA, where Kco is measured as a concentration fall in 
alveolar CO per unit time per unit CO driving pressure (PA,CO): Kco=Δ[CO]/Δt/ PA,CO and 
VA is the volume of gas in the lung containing CO. VA = IVC x (He inspired 
concentration/alveolar sample He gas concentration). 
The term “diffusion capacity” is commonly used, but does not fully reflect that it is a 
conductance and that CO uptake involves passive diffusion over the alveolar and red cell 
membrane, and chemical binding with haemoglobin (Hb). 
 CO uptake can be simplified into two conductance properties (in series) as follows: 
membrane conductivity (DM) and the binding of CO and Hb. DM reflect the diffusion 
properties of the alveolar capillary membrane and the erythrocyte membrane. The binding 
of CO-Hb can be represented as θVc; θ is the rate with which CO combine with intracellular 
Hb in 1 mL of blood expressed as mL CO/min/mmHg while Vc is the volume of Hb in 
alveolar capillary blood (the volume of capillary bed available for gas exchange (in mL), 
independent of the packed cell volume). 
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Physiologic changes in DM or θVc thereby influence DLCO. 
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